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ABSTRACT OF THE DISSERTATION 
 
TREATMENT MODERATION AND SECONDARY OUTCOMES: RESULTS FROM 
A RANDOMIZED CLINICAL TRIAL  
by 
 
Luci M. Motoca 
 
Florida International University, 2012 
 
Miami, Florida 
 
Professor Wendy K. Silverman, Major Professor 
The present study pursued two objectives in the context of a randomized clinical 
trial of cognitive-behavioral therapy with parent (CBT/P) and group (GCBT) 
involvement. The first objective was to examine the variability in treatment outcome. 
There were three specific aims within the first objective, to evaluate: (1) youth 
characteristics (age, depressive, and externalizing disorders) as moderators of treatment 
outcome; (2) the differential outcome of the treatment approaches as a function of youth 
characteristics; and (3) the relative efficacy of the treatment approaches at each level of 
the moderators.  
The second objective was to evaluate the efficacy of anxiety treatments along 
secondary depressive symptoms and externalizing behaviors. There were five specific 
aims within the second objective, to evaluate: (1) whether anxiety treatment yields 
reductions in secondary problems, (2) the efficacy of anxiety treatments in reducing 
secondary problems as a function of approach and youth characteristics, (3) whether 
reductions in anxiety symptoms significantly mediate changes in secondary problems, (4) 
the directionality of change in the hypothesized mediated relations, and (5) whether the 
 vi 
hypothesized mediated relations are moderated by treatment approach and youth 
characteristics. The specific aims were pursued using data collected from 183 youth and 
their mothers. Research questions were tested using multiple regressions and structural 
equation modeling.  
Age, depressive, and externalizing disorders were significant moderators. CBT/P 
relative to GCBT lowered anxiety more for younger than older youth. GCBT relative to 
CBT/P lowered anxiety more for older than younger youth. GCBT relative to CBT/P 
lowered anxiety more for depressed youth than non-depressed youth. GCBT relative to 
CBT/P lowered anxiety less for externalizing youth than non-externalizing youth. 
Treatment reduced depressive symptoms and externalizing problem behaviors. 
Reductions in anxiety mediated changes in depressive symptoms and externalizing 
problem behaviors. Reversed directionality was found in the relation between social 
anxiety and depressive symptoms. In CBT/P the direction of change was from depressive 
to social anxiety. The opposite was true in GCBT. Reductions in social anxiety mediated 
posttreatment changes in depressive symptoms in GCBT but not CBT/P. The reverse was 
true at follow-up. Reductions in social anxiety mediated changes in depressive symptoms 
for girls but not boys.  
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CHAPTER I 
INTRODUCTION 
Anxiety disorders in children and adolescents (hereon referred to as youth) are 
serious, multifaceted problems, which impact not only youth, but also their families and 
the broader society. Epidemiological studies have shown that anxiety disorders are the 
earliest and most common psychiatric problems in young people, with prevalence rates 
ranging from 7% to 28% (see Costello, Egger, Copeland, Erkanli, & Angold, 2011, for 
review). Anxiety disorders are chronic conditions that last into adulthood and have low 
recovery rates (e.g., Last, Perrin, Hersen, & Kazdin, 1996; Woodward & Fergusson, 
2001). Left untreated, anxiety disorders develop into other psychological disorders, 
including other anxiety and depressive disorders (e.g., Goodwin, Fergusson, & Horwood, 
2004; Pine, Cohen, Gurley, Brook, & Ma, 1998). Anxiety disorders in youth are also 
associated with difficulties in family functioning, peer relationships, and school 
adjustment (e.g., Ginsburg, La Greca, & Silverman, 1998; Motoca, Williams, & 
Silverman, 2012; Strauss, Frame, & Forehand, 1987). 
Cognitive Behavioral Treatment for Reducing Anxiety Disorders   
Given the prevalence, chronicity, and deleterious outcomes of anxiety disorders in 
youth, a number of well-designed and well-executed randomized clinical trials (RCTs) 
have been conducted aimed at reducing these problems (e.g., see Silverman & Motoca, 
2011; Silverman, Pina, & Viswesvaran, 2008; for reviews). These RCTs have provided 
strong and consistent empirical evidence for the efficacy of cognitive behavioral 
treatment (CBT) for youth anxiety and its disorders. Evidence of efficacy is available 
based on indices of primary outcome (i.e., reductions in anxiety symptoms and diagnostic 
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recovery rates for the targeted anxiety disorder) and has been demonstrated in several 
approaches (e.g., individual, group, parent involvement). Despite research supporting the 
efficacy of CBT for reducing anxiety and its disorders in youth, two important unresolved 
issues remain.  
Moderators of Treatment Outcome 
The first important unresolved issue is that CBT for anxiety and its disorders is 
not effective across the board: upward to 50% of the treated youth in some studies 
continue to meet diagnostic criteria for their targeted anxiety disorder and remain 
symptomatic after CBT (e.g., Ginsburg et al., 2011; Silverman et al., 2008). After two 
decades of treatment research aimed at reducing youth anxiety and its disorders, why do 
researchers continue to observe such variability in treatment outcome? Perhaps one of the 
main reasons is because youth with anxiety disorders are heterogeneous in nature. Youth 
with anxiety disorders often differ in terms of sociodemographic (e.g., age) and clinical 
(e.g., comorbidity with depressive and externalizing problems) characteristics (e.g., 
Kendall et al., 2010). It is therefore possible that treatment efficacy varies among 
subgroups of youth who differ on these and other variables. 
One approach used to examine the extent to which efficacy varies among 
subgroups of treated youth involves testing for moderators of treatment outcome. 
Moderators are variables that influence the strength of the relation between treatment and 
outcome to identify subgroups of youth with particularly strong or weak treatment 
outcome (e.g., Hinshaw, 2007; Kazdin, 2007; Kazdin & Nock, 2003; Kraemer, Wilson, 
Fairburn, & Agras, 2002; La Greca, Silverman, & Lochman, 2009). Examples of 
moderators include characteristics of the youth, parents and therapists, which interact 
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with treatment approach to either strengthen or weaken treatment outcome (e.g., La 
Greca et al., 2009).  
Testing for moderators of treatment outcome is important for theoretical, 
empirical, and clinical reasons. Theoretically, knowledge of moderators can inform 
theories about the development and maintenance of psychopathology (Howe, Reiss, & 
Yuh, 2002). As noted by Kraemer, “Moderators could identify subpopulations with 
possibly different course of illness and may also provide unique new and valuable 
information to guide future restructuring of diagnostic classification” (p. 4, Kraemer et 
al., 2002).  
Empirically, knowledge of moderators could open avenues for future research 
aimed at unearthing the processes that work in specific subgroups to either strengthen or 
weaken treatment outcome (e.g., Kazdin, 2001). Testing for moderators therefore is not a 
be-all and end-all undertaking but one that serves as a springboard to examine why and 
how the moderators operate the way they do in future work (e.g., Kraemer et al., 2002). 
In addition, empirical research on moderators can be used to improve statistical power in 
future RCTs in that it will lead to the selection of the subgroups of youth for whom 
specific treatments work particularly well (Kraemer et al., 2002). Knowledge of 
moderators also can prompt searches for innovative treatments for the subgroups of youth 
for whom specific treatments do not work as well (Kraemer et al., 2002). 
Clinically, testing for moderators answers calls in the literature to move beyond 
determining whether treatment works to examining for whom or under what conditions it 
works (e.g., Hinshaw, 2007; Kazdin, 2001; Kazdin, 2007; Kazdin & Nock, 2003; 
Kraemer, Wilson, Fairburn, & Agras, 2002; La Greca et al., 2009). Testing for 
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moderators of treatment outcome is also consistent with the third strategic objective put 
forth by the National Institute of Mental Health Strategic Plan -- "to develop new and 
better interventions for mental disorders that incorporate the diverse needs and 
circumstances of people with mental illness” (NIMH; U.S. Department of Health and 
Human Services, 2008). The NIMH, in other words, calls for personalized approaches 
that are tailored to the specific needs of each individual. 
Although important for the above reasons, testing for moderators has been an 
exception not a rule. The reason for this is because traditional intervention research has 
focused on comparing how groups of individuals receiving an experimental intervention 
fare against a comparison group that does not receive the intervention (e.g., Kraemer et 
al., 2002; NIMH; U.S. Department of Health and Human Services, 2008). This approach 
has yielded information about which treatments are efficacious overall but not about how 
to choose the best treatment for the specific needs of individuals (Kraemer et al., 2002; 
NIMH; U.S. Department of Health and Human Services, 2008). Clinical trials that gather 
a multitude of data and use these data to test for moderators are posed to answer 
questions that can inform personalized decision making in treatment interventions 
(NIMH; U.S. Department of Health and Human Services, 2008). Only a small number of 
studies have tested for treatment moderators (see Chapter 2, Literature Review for further 
details). Although these initial treatment moderation studies represent valuable efforts, 
significant gaps and limitations in this research remain, as discussed in this dissertation. 
Secondary Treatment Outcomes 
The second important unresolved issue pertains to the assessment of treatment 
efficacy for anxiety and its disorders along secondary or nontargeted outcomes. The 
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impetus to examine the efficacy of CBT for anxiety and its disorders in terms of 
reductions in depressive symptoms and externalizing problem behaviors, in particular, 
stems from knowledge that anxiety, depressive and externalizing problems co-occur (e.g., 
Angold, Costello, &  Erkanli, 1999; Brady & Kendall, 1992; Costello, Mustillo, Erkanli, 
Keeler, & Angold, 2003). The impetus also stems from knowledge that youth with 
comorbid anxiety and depressive symptoms, as well as youth with comorbid anxiety 
symptoms and externalizing problem behaviors, experience more severe psychosocial 
problems than youth with pure anxiety symptoms both concurrently and sequentially 
(e.g., Franco, Saavedra, & Silverman, 2007; Strauss, Last, Hersen, & Kazdin, 1988). To 
examine a broad range of anxiety treatment efficacy, it is therefore important to assess 
secondary outcomes in addition to primary anxiety outcomes. 
Evaluation of treatment efficacy along secondary outcomes also is important for 
theoretical, empirical, and clinical reasons (e.g., LoCastro et al., 2009). Theoretically, 
evaluation of treatment efficacy along secondary outcomes may inform classification 
efforts (e.g., Lahey, Applegate, Waldman, Loft, Hankin, & Rick, 2004; Masten et al., 
2005). Classification efforts regarding anxiety, depressive, and externalizing symptoms 
revolve around lumping versus splitting (e.g., Lahey et al., 2004). Because anxiety, 
depressive, and externalizing symptoms often co-occur across development there is an 
ongoing debate about common and distinct features of these problems. Anxiety and 
depressive symptoms are viewed as manifestations of a broad internalizing dimension 
that is distinct from an externalizing dimension comprising of attention deficit 
hyperactivity disorder (ADHD), oppositional and conduct disorders, and substance abuse 
(e.g., Lahey et al., 2004). Classification efforts also revolve around whether anxiety and 
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depressive symptoms are distinct enough in youth to warrant separate disorders (e.g., 
Brady & Kendall, 1992). 
Empirically, evaluation of treatment efficacy along secondary outcomes may 
inform researchers about the secondary outcome measures that demonstrate sensitivity to 
treatment and the utility of including secondary outcome measures in RCTs (e.g., 
LoCastro et al., 2009). Clinically, evaluation of treatment efficacy along secondary 
outcomes may broaden the focus of interventions to treating not only the anxiety in the 
person but also psychological difficulties that co-occur with it (NIMH; U.S. Department 
of Health and Human Services, 2008). Knowledge gathered from evaluation of treatment 
efficacy along secondary problems also may inform policy makers about the types of 
treatment programs that are needed and when they are needed (Hudson, Kendall, Coles, 
Robin & Webb, 2002; LoCastro et al., 2009). 
Although important for the above reasons, only a small number of RCTs for youth 
anxiety have assessed secondary outcomes in addition to primary anxiety outcomes (see 
Chapter 2, Literature Review for further details). These initial studies on secondary 
outcomes represent valuable initial efforts, yet important questions remain as further 
discussed in this dissertation.  
Objectives and Specific Aims of the Present Study 
The important unresolved issues discussed pertaining to treatment moderation and 
secondary outcomes map onto the two primary objectives of this dissertation study, 
which will be examined using data collected within the context of a RCT of CBT with 
parent (CBT/P) and group (GCBT) approaches for youth anxiety and its disorders. The 
first study objective is to examine variability in treatment outcome in 12 to 14 week 
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CBTs aimed at reducing youth anxiety and its disorders. There are three specific aims for 
the present study’s first objective, to evaluate: (1) youth characteristics as moderators of 
treatment outcome; (2) the differential outcome of each of the treatment approaches as a 
function of youth characteristics; and (3) the relative efficacy of the treatment approaches 
at each level of the hypothesized moderator variables. 
The second objective is to examine the efficacy of CBTs aimed at reducing 
anxiety and its disorders along secondary outcomes (i.e., depressive symptoms and 
externalizing problem behaviors). There are five specific aims within the second 
objective, to evaluate: (1) whether anxiety treatment yields reductions in secondary 
problems, (2) the efficacy of anxiety treatments in reducing secondary problems as a 
function of approach and youth characteristics, (3) whether reductions in anxiety 
symptoms significantly mediate changes in secondary problems, (4) the directionality of 
change in the hypothesized mediated relations, and (5) whether the hypothesized 
mediated relations and the directionality of change between changes in primary anxiety 
symptoms and secondary outcome problems are moderated by treatment approach 
(CBT/P versus GCBT) and youth characteristics (sex and age). The present study pursues 
these specific aims at posttreatment and 12 month follow-up.  
Organization of the Present Dissertation  
This dissertation is organized as follows. The dissertation begins with an 
overview of CBT outcome studies on anxiety and its disorders in youth. This overview 
contextualizes the present study’s objectives within the broader intervention research 
literature on youth anxiety and its disorders as it relates to two lines of research: (1) 
research that seeks to understand the variability in treatment outcome by testing for 
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predictors and moderators along indices of primary (i.e., targeted) anxiety problems, and 
(2) research that examines treatment outcome along indices of secondary (i.e., non-
targeted) problems. 
 The Literature Review section summarizes the studies that are related to these 
two lines of psychotherapy research. It also highlights gaps in each of these two lines of 
research and outlines the study’s research questions. The next section discusses the 
dissertation’s methodology to address the study’s research questions. This is followed by 
a presentation of the dissertation findings. The final section summarizes the dissertation’s 
findings, its contributions and limitations. 
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CHAPTER II 
LITERATURE REVIEW 
 Overview of Treatment Outcome Studies  
In the past two decades, a growing body of literature has emerged on the 
treatment of anxiety and its disorders in youth, with over 30 RCTs (e.g., see Silverman et 
al., 2008; Silverman & Motoca, 2011 for reviews). Embedded within this literature are 
several lines of intervention  research that evaluate: (1) efficacious and effective 
approaches in reducing primary or targeted anxiety problems, (2) predictors and 
moderators in order to understand the variability in treatment outcome, and (3) 
efficacious and effective approaches in reducing secondary or non-targeted problems. 
The Literature Review now turns to an overview of the three lines of intervention 
research. Emphasis is placed on the lines of intervention research on treatment 
moderation and secondary outcomes, which are directly relevant to the present study. 
Treatment Efficacy Studies  
The first line of research seeks to design and evaluate treatments for youth anxiety 
and its disorders. This line of research seeks to answer questions about potentially overall 
efficacious treatments. The key questions asked are the following: Does treatment work? 
Is treatment efficacious? The basic design of treatment outcome studies involves the 
random assignment of participants to the approaches of interest. The core statistical 
analyses used to examine whether treatment is efficacious focus on the main effect of 
treatment on primary outcome measures from pretreatment to posttreatment and from 
posttreatment to follow-up. When the relative efficacy of two or more treatment 
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approaches is compared, the key questions become: What treatment approach is most 
efficacious? What treatment approach works best?  
Silverman et al. (2008) summarized the literature on treatment outcome and found 
most of the treatment studies were methodologically robust based on criteria for 
efficacious treatments (Chambless & Hollon, 1998; Nathan & Gorman, 2002). Several of 
the CBTs reviewed were classified as “probably efficacious” and “possibly efficacious” 
according to criteria for efficacious treatments. Silverman et al.’s (2008) review begins 
with the first RCT by Kendall (1994) in which individual CBT (ICBT) was demonstrated 
to be superior to a waitlist. ICBT fosters change by teaching youth cognitive skills and 
behavioral strategies to manage their anxiety.  
Next, Barrett, Dadds, and Rapee (1996) replicated Kendall’s positive findings for 
the CBT program, and developed a parent program to investigate the possible added 
benefit of parent involvement. In addition to teaching youth cognitive skills and 
behavioral strategies to manage their anxiety, CBT/P (and in some studies CBT with 
family involvement or CBT/F) approaches foster change by teaching parents 
reinforcement skills (e.g., Barrett, 1998; Barrett et al., 1996; Kendall, Hudson, Gosch, 
Flannery-Schroeder, & Suveg, 2008) and improving parents’ behaviors and the parent-
youth relationship (e.g., Bodden, Bögels, Nauta, De Hann, Ringrose, Appelboom, 
Brinkman, & Appelboom-Gerts, 2008; Silverman, Kurtines, Jaccard, & Pina, 2009; 
Wood, Piacentini, Southam-Gerow, Chu, & Sigman, 2006).  
Within this first line of research, several RCTs evaluated the efficacy of GCBT 
with and without parent involvement (e.g., Beidel, Turner, & Morris, 2000; Flannery-
Schroeder & Kendall, 2000; Hayward, Varardy, Albano, Thienemann, Henderson, & 
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Schatzberg, 2000; Silverman, Kurtines, Ginsburg, Weems, Lumpkin, & Hicks-
Carmichael, 1999b). In addition to teaching youth cognitive skills and behavioral 
strategies to manage their anxiety, GCBT approaches foster change by teaching peers 
reinforcement skills and improving youths’ social skills behaviors and the peer-youth 
relationship (e.g., Barrett, 1998; Beidel et al., 2000; Flannery-Schroeder & Kendall, 
2000; Hayward et al., 2000; Spence et al., 2000). 
In terms of treatment efficacy, Silverman et al.’s (2008) review revealed that 
CBTs in general demonstrated positive outcomes. About 50% of the treated youth no 
longer meet diagnostic criteria for their targeted anxiety disorder and report reductions in 
anxiety symptoms that are robust across youth and parent ratings. Positive outcomes have 
been demonstrated at posttreatment and generally maintained at follow-up. Positive 
outcomes were demonstrated when CBTs were delivered to the individual child, to the 
child and his or her parents (usually mothers), and to the child and his or her peers, with 
generally no statistically significant differences between treatment approaches. However, 
upward to 50% of the treated youth in some studies continue to meet diagnostic criteria 
for their targeted anxiety disorder and remain symptomatic after CBT (e.g., Ginsburg et 
al., 2011; Silverman et al., 2008). This knowledge has prompted a second line of research 
that seeks to understand variability in treatment outcome. 
Treatment Variability Studies  
This second line of research seeks to understand variability in treatment outcome 
focusing on the evaluation of predictors and moderators (e.g., Kraemer et al., 2002). 
There are both similarities and differences when it comes to predictors and moderators of 
treatment outcome. Understanding the similarities and differences is important because 
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key processes relating to treatment outcome tend to be confused in the field, conceptually 
and statistically. Such confusion can be consequential for how research findings are 
interpreted and applied in research and clinical practice (e.g., Jaccard & Guilamo-Ramos, 
2002; Kraemer et al., 2002). 
In terms of similarities, both predictors and moderators are variables measured at 
pretreatment (e.g., Kraemer et al., 2002). In terms of differences, predictors are 
pretreatment variables that account for outcome for the overall treatment sample or 
irrespective of the type of approach received. The key question asked is the following: 
What are the characteristics of youth who (fail to) demonstrate positive treatment 
outcome? The core statistical analyses used to examine predictors of treatment outcome 
focus on the main effect of pretreatment variables on primary treatment outcome 
measures at posttreatment and follow-up (e.g., Jaccard & Guilamo-Ramos, 2002). 
Predictors of treatment outcome can be evident, for instance, when high levels of youth 
depressive symptoms are related to high levels of youth anxiety symptoms after treatment 
irrespective of the type of approach received (La Greca et al., 2009). 
Moderators of treatment outcome are pretreatment variables that influence the 
relation between the type of treatment and outcome (e.g., Kazdin, 2008; Kramer et al., 
2002). The key question asked is: For whom and under what conditions does treatment 
demonstrate positive outcomes? The core statistical analyses to examine moderators of 
treatment outcome focus on the interaction effect of treatment approach by pretreatment 
variables in relation to treatment outcomes (e.g., Jaccard & Guilamo-Ramos, 2002). A 
statistically significant interaction effect could be found with or without a main effect of 
treatment on primary outcome measures. A statistically significant interaction effect 
13 
 
could therefore be found even in the absence of a statistically significant difference 
between the treatment approaches (e.g., CBT/P versus GCBT). A statistically significant 
interaction effect could also be found even in the absence of a statistically significant 
main effect of pretreatment variables on primary outcome measures. Put differently, not 
all predictors are moderators. Because predictors of treatment outcome using the present 
study’s dataset have been examined elsewhere (Motoca, 2009), of interest in this 
dissertation are treatment moderators.  
Examining Moderators: The Exception Rather than the Rule  
Reviews of treatment outcome research suggest CBT is the most frequently 
investigated and most empirically supported treatment for youth anxiety and its disorders 
(e.g., Silverman et al., 2008). Efficacy studies investigating CBT with anxious youth have 
produced positive results generally with no statistically significant differences between 
treatment approaches. An issue that may be important to consider is not only whether a 
treatment is more efficacious than another, but under what circumstances an approach 
yields stronger outcomes than another. This question is of interest even when, on average, 
the treatment approaches do not differ in their relative efficacy. 
Given the heterogeneity of the population of youth with anxiety disorders it is 
important to evaluate: (1) youth characteristics (age, depressive, and externalizing 
disorders) as moderators of treatment outcome; (2) the differential outcome of the 
treatment approaches as a function of youth characteristics; and (3) the relative efficacy 
of the treatment approaches at each level of the moderators. Answers to these questions 
may help clinicians tailor treatment approaches to the specific needs of individuals. The 
alternative is a trial and error approach whereby various treatments are attempted on the 
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individual child with little theoretical or empirical data to guide whether the treatment 
would work. 
Because youth anxiety RCTs have only been reported since 1994 with publication 
of Kendall (1994), studies on treatment moderators have been the exception rather than 
the rule. There is currently only one study that has focused specifically on treatment 
moderators (Alfano, Pina, Villalta, Beidel, Ammerman, & Crosby, 2009). A small 
number of studies have reported on moderators when presenting the main treatment 
outcomes from the respective RCT (e.g., Bodden et al., 2008; Liber, Van Widenfelt, 
Utens, Ferdinand, Van der Leeden, & Van Gastel, 2008; Manassis, Mendlowitz, 
Scapillato, Avery, Fiksenbaum, & Freire, 2002). These studies have examined youth (i.e., 
age, depression, social anxiety) and parent (i.e., anxiety) variables as moderators of 
treatment outcome. By way of background and to highlight the little work that has been 
done on moderators of treatment outcome, all of these studies are summarized below. 
Directly relevant to the present study are studies in which youth sociodemographic (i.e., 
age) and clinical (i.e., comorbidity) characteristics were tested as potential moderators.  
Youth Variables as Moderators of Treatment Outcome 
Youth Age. Treatment studies involving CBT approaches for anxious youth have 
focused on youth from 7 to 16 years, but only two studies tested youth age as a moderator 
of treatment outcome (Alfano et al., 2009; Bodden et al., 2008). In a sample of 128 youth 
(8 to 17 years), Bodden et al. (2008) examined efficacy of CBT (n = 64) and CBT with 
family involvement (CBT/F; n = 64). Both parents (91% fathers; 98% mothers) and 
siblings participated in the study. Bodden et al. (2008) examined whether treatment 
approach (i.e., CBT vs. CBT/F) would interact with youth age on diagnostic recovery 
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rates and anxiety symptoms at posttreatment and 3 month follow-up. The rationale for 
examining youth age as a moderator was that family factors may be more influential for 
younger children, who tend to depend on their parents; family factors may be less 
influential for older children, who tend to seek autonomy from their parents. The 
hypotheses put forth therefore were that CBT/F would be particularly efficacious for 
younger children and that CBT would be particularly efficacious for older children. 
Results indicated that youth age was not a moderator of treatment outcome though 
perhaps low statistical power, a limitation that applies to other studies and that will be 
further discussed in this dissertation, may explain the null finding. 
Alfano et al., (2009) pooled data from two previously published RCTs (i.e., 
Beidel, Turner, & Morris, 2000; Beidel, Turner, Sallee, Ammerman, Crosby, & Pachak, 
2007) to examine moderators of treatment outcome in a sample of 88 youth (ages 7 to 17 
years) with a primary diagnosis of social phobia (SOP). Youth were randomized to either 
Social Effectiveness Training for Children (SET-C; n = 57, Beidel et al., 2007) or the 
control condition, Testbusters (n = 31; Beidel et al., 2000). SET-C (Beidel, Turner, & 
Morris, 1998) is a behavioral approach adapted after a program used for adults with SOP 
(Turner, Beidel, & Cooley-Quille, 1997). SET-C fosters change in youth social anxiety 
through targeting social skills, interpersonal functioning, and participation in social 
activities (Beidel et al., 2008).  
Alfano et al. (2009) examined whether clinical severity ratings (CSRs), social 
anxiety symptoms, and global impairment interacted with youth age to moderate 
treatment outcome in SET-C. The CSRs were assessed using the Anxiety Disorders 
Interview Schedule for Children-Child and Parent Versions (ADIS-C/P; Silverman & 
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Albano, 1996); social anxiety symptoms were assessed using the Social Phobia and 
Anxiety Inventory for Children (SPAI-C; Beidel, Turner, & Morris, 1995); global 
impairment was assessed using the Children's Global Assessment Scale (C-GAS; Shaffer 
et al., 1983). The hypothesis that older youth age would moderate treatment outcome in 
SET-C was not supported. Of further note, Alfano et al. (2009) also tested youth 
depressive symptoms as a moderator of treatment outcome in SET-C. Results indicated 
that youth depressive symptoms did not moderate treatment outcome in SET-C. Overall, 
in both Bodden et al., (2008) and Alfano et al. (2009), youth age was not a significant 
moderator of treatment outcome. Both Bodden et al., (2008) and Alfano et al. (2009) did 
not test for moderators at 12 month follow-up, a limitation that applies to other studies on 
treatment moderators and that will be further discussed in this dissertation.   
Youth Social Anxiety. Two past studies tested for social anxiety as a moderator of 
treatment outcome in comparative trials of the relative efficacy of ICBT and GCBT 
(Liber et al., 2008; Manassis et al., 2002). The rationale for testing for social anxiety as a 
moderator was that the group approach would afford additional social exposures for 
socially anxious youth and therefore more opportunities for social desensitization than 
the individual approach. The hypothesis put forth therefore was that children with high 
levels of social anxiety (SA) and children with diagnosable SOP would improve more in 
GCBT relative to ICBT.  
Manassis et al. (2002) examined the relative efficacy of ICBT (n = 41) and GCBT 
(n = 47) in reducing anxiety symptoms in children (ages 8 to 12 years). Manassis et al. 
(2002) dichotomized their sample into children with low and high levels of SA symptoms 
based on the Social Anxiety Scale for Children (SASC; La Greca & Stone, 1993). 
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Manassis et al. (2002) tested the interaction between treatment approach and low versus 
high levels of SA symptoms on treatment outcome. Results indicated that levels of SA 
symptoms moderated treatment outcome based on children’s ratings of anxiety symptoms 
on the Multidimensional Anxiety Scale for Children (MASC; March, Parker, Sullivan, 
Stallings, & Conners, 1997). The results were in the opposite direction than expected. 
There were greater child rated reductions in anxiety symptoms in ICBT relative to GCBT 
among children with high levels of SA symptoms. The levels of SA symptoms did not 
moderate treatment outcome based on mothers’ and fathers’ ratings of their child’s 
anxiety symptoms on the MASC. Manassis et al. (2002) suggested the group approach 
may have been overwhelming for socially anxious children making them less likely to 
fully benefit from treatment.   
Liber et al. (2008) examined the relative efficacy of ICBT (n = 41) and GCBT (n 
= 47) in reducing anxiety symptoms in children (ages 8 to 12 years). Liber et al. (2008) 
tested the interaction between type of treatment and diagnosable SOP on treatment 
outcome. Results indicated that SOP moderated treatment outcome based on fathers’ 
ratings of their child’s anxiety symptoms on the Internalizing broadband scale of the 
Child Behavior Checklist (CBCL-I; Achenbach & Rescorla, 2001). GCBT relative to 
ICBT lowered anxiety symptoms significantly more for children with SOP than children 
without SOP. This interaction effect was not found based on children’s self-ratings of 
anxiety symptoms on the MASC, nor based on mothers’ ratings of their child’s anxiety 
symptoms on the CBCL-I.  
Overall, Manassis et al. (2002) and Liber et al. (2008) produced inconsistent 
findings. ICBT relative to GCBT lowered anxiety symptoms significantly more for 
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children with high levels of SA symptoms in Manassis et al. (2002). GCBT relative to 
ICBT lowered anxiety symptoms significantly more for children with SOP than for 
children without SOP in Liber et al. (2008). Both sets of findings were not robust across 
informants. Both Manassis et al. (2002) and Liber et al. (2008) did not test for moderators 
at 12 month follow-up. 
Parent Variables as Moderators of Treatment Outcome 
Parental Anxiety. Two past studies tested for parental anxiety as a moderator of 
treatment outcome in studies comparing the relative efficacy of ICBT and CBT/F or 
CBT/P (Bodden et al., 2008; Kendall et al., 2008). In both studies parental anxiety was 
assessed using the Anxiety Disorder Interview Schedule for DSM–IV, Lifetime Version 
(ADIS-IV-L; DiNardo, Brown, & Barlow, 1994). Of interest was the interaction between 
treatment approach and parental diagnostic status (i.e., mothers with anxiety disorders 
versus mothers without anxiety disorders; fathers with anxiety disorders versus fathers 
without anxiety disorders; both parents with anxiety disorders versus both parents 
without anxiety disorders). Youth whose parents suffered from anxiety disorders were 
expected to improve more in CBT/F or CBT/P than ICBT. 
Bodden et al., (2008) examined the relative efficacy of ICBT (n = 64) and CBT/F 
(n = 64). Both parents (91% fathers; 98% mothers) and siblings participated in the study. 
Bodden et al. (2008) examined whether the treatment approach (ICBT vs. CBT/F) would 
interact with parental anxiety on diagnostic recovery rates and anxiety symptoms at post-
treatment and 3 month follow-up. Measures included the Screen for Child Anxiety 
Related Emotional Disorders (SCARED; Birmaher, Khetarpal, Brent, Cully, Balach, 
Kaufman et al., 1997) and the State Trait Anxiety Inventory (STAI; Spielberger, 1973) 
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completed by the youth (SCARED-C; STAI-C) and by the parents (SCARED-P; STAI-
C); the CBCL completed by the parents, and the Children's Automatic Thoughts Scale 
(CATS; Schniering & Rapee, 2002) completed by the youth.  
Results indicated that parental anxiety was a significant moderator of treatment 
outcome, however, in the opposite direction than expected and only on one measure. 
ICBT was particularly efficacious for youth whose parents had anxiety disorders 
themselves; CBT/F was particularly efficacious for youth whose parents did not have 
anxiety disorders themselves. For youth whose parents had anxiety disorders significantly 
more fell within the normal range of the SCARED-C after CBT (46% at posttreatment; 
75% at 3 month follow-up) than after CBT/F (19% at posttreatment; 46%, at 3 month 
follow-up). For youth whose parents did not have anxiety disorders, significantly more 
fell within the normal range of the SCARED-C after CBT/F (62% at post-treatment; 73% 
at 3 month follow-up) than after ICBT (55% at post-treatment; 63% at 3 month follow-
up). This interaction effect was not found based on the SCARED-P, nor the STAI-C and 
STAI-P. Bodden et al. (2008) suggested parental anxiety may have blocked the transfer 
of control of CBT skills from parents to youth in CBT/F which may explain why ICBT 
was particularly efficacious for youth whose parents had anxiety disorders themselves; 
CBT/F was particularly efficacious for youth whose parents did not have anxiety 
disorders themselves.(e.g., Ginsburg, Silverman, & Kurtines, 1995). 
Kendall et al. (2008) examined the relative efficacy of ICBT (n = 55), CBT/P (n = 
56), and education/support/attention with parents (ESA/P; n = 50) in a sample of 161 
youth (ages 7 to 14 years) diagnosed with an anxiety disorder. Kendall et al. (2008) 
examined whether the treatment approach (i.e., ICBT, CBT/P, ESA/P) would interact 
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with parental anxiety on anxiety symptoms at posttreatment and 12 month follow-up. 
Measures included the MASC completed by the youth and CBCL-I completed by the 
parents. 
Results indicated that parental anxiety was a significant moderator of treatment 
outcome from posttreatment to 12 month follow-up. Youth with an anxious father who 
received ICBT showed significantly less reductions in anxiety symptoms on the MASC 
from posttreatment to 12 month follow-up than children with an anxious father who 
received CBT/P. This interaction effect from posttreatment to 12 month follow-up was 
not found based on parents’ ratings of their children’s anxiety symptoms on the CBCL-I. 
Parental anxiety was not a significant moderator of treatment outcome from pretreatment 
to posttreatment. Analyses also examined the interaction between parent anxiety and 
treatment approach in relation to child diagnostic outcomes. The results of these analyses, 
however, were not reported due to small cell sizes although the authors’ conclusion was 
that parental anxiety was not a significant moderator of treatment outcome. 
Summary of Studies on Treatment Moderators 
 Moderators of treatment outcome were tested in a small number of studies. Two 
reasons have been put forth as to why moderators of treatment outcome have been 
infrequently tested (e.g., Silverman & Motoca, 2011). The first reason is that most 
treatment studies were conducted primarily to investigate whether CBT is efficacious. 
The second reason is that most treatment studies were insufficiently powered to 
systematically test for moderators (e.g., Kendall et al., 2008). The studies summarized 
above represent initial valuable efforts toward advancing the knowledge base on 
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moderators of treatment outcome; yet three gaps in treatment moderation research 
remain.  
 First, prior research on treatment moderation examined youth age and 
comorbidity, variables directly relevant to the present study, in the context of RCTs 
comparing the relative efficacy of ICBT versus CBT/P (i.e., Bodden et al., 2008) or SET-
C versus Testbusters (i.e., Alfano et al., 2009). Moderators of treatment outcome are yet 
to be examined in the context of RCTs comparing the relative efficacy of CBT/P versus 
GCBT. This is because although there now exists considerable empirical evidence that 
youth anxiety and its disorders can be reduced in CBT programs that incorporate parents 
and group contexts and target specific content areas relevant to these contexts, no 
published RCTs have directly evaluated the relative efficacy of CBT/P and GCBT in the 
same investigation. The present study was in the unique position to test for moderators in 
the context of a RCT that directly evaluated the relative efficacy of CBT/P and GCBT in 
the same investigation (Marin, 2010). Testing for moderators in this way is timely 
because statistically significant reductions in anxiety symptoms have been demonstrated 
with both treatment approaches (Marin, 2010). It is now important to examine individual 
differences in the effects of CBT/P and GCBT or for whom these treatment approaches 
yield the strongest and weakest outcomes (e.g., Kraemer et al., 2002). 
Second, prior research on treatment moderation has not paid attention to youth 
age and comorbidity as moderators at 12 month follow-up. Testing for youth age and 
comorbidity as moderators at 12 follow-up is important because such analyses would 
reveal whom and under what conditions maintains their therapeutic change, makes 
additional gains or deteriorates over a relatively long period of time. Knowledge gathered 
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from testing for moderators both at posttreatment and 12 follow-up can illuminate the 
importance of time and timing in therapeutic change (e.g., Granic, 2006; Silverman et al., 
2009).  
In pursuing questions about time and timing, for example, some investigators 
have described lagged effects in the process of therapeutic change (e.g., Jaccard & 
Jacoby, 2010; Silverman et al., 2009). Silverman et al. (2009) examined whether youth 
anxiety between pretreatment and posttreatment, as reported by parent and youth, served 
as a mediator between parent variables (i.e., parental positive-negative behaviors towards 
the child, conflict in the parent-youth dyadic relationship, and parental anxiety) measured 
at posttreatment and parent variables measured at 12 month follow-up. Findings indicated 
changes in youth anxiety from pretreatment to posttreatment mediated changes in parent 
anxiety during the same time period.  Findings also indicated a lagged effect such that it 
took time for changes in youth anxiety from pretreatment to posttreatment to yield 
changes in positive parenting behaviors, measured at the 12 month follow-up. Such 
lagged effects make theoretical sense because time may need to pass for changes in one 
variable to work their way through and produce changes in another variable. 
Testing for treatment moderators at both posttreatment and 12 month follow-up 
constitutes another approach to understanding the importance of time and timing in 
therapeutic change. If an individual characteristic (e.g., presence of depression) interacts 
with treatment to moderate posttreatment but not 12 month follow-up outcomes, this 
would suggest that youth who share that characteristic may need additional time to “catch 
up” in anxiety symptom reduction with youth who do not share that characteristic and 
this may vary by treatment approach. If an individual characteristic (e.g., presence of 
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depression) interacts with treatment to moderate 12 month follow-up but not 
posttreatment outcomes, this would suggest that youth who share that characteristic may 
deteriorate over time relative to youth who do share that characteristic and this may vary 
by treatment approach. Testing for treatment moderators at both posttreatment and 12 
month follow-up could therefore identify subgroups of youth with different course of 
therapeutic change (e.g., Kraemer et al., 2002).  
Third, prior research on treatment moderation is limited because most studies 
relied on traditional data analytic techniques to test for moderators. Traditional data 
analytic techniques have several caveats when it comes to testing for moderators of 
treatment outcome (e.g., Jaccard & Guilamo-Ramos). These caveats are discussed next as 
part of methodological issues in testing for treatment moderators.  
Methodological Issues in Testing for Treatment Moderators 
Jaccard and Guilamo-Ramos (2002) discussed that the traditional approach to 
interpreting a statistically significant interaction effect in a factorial design is to use 
simple main effects analysis. Jaccard and Guilamo-Ramos (2002) further discussed that 
simple main effects address the question of whether an independent variable has an effect 
on a dependent variable at each level of a moderator variable. For example, when testing 
for youth age as a moderator, researchers might ask if the treatment approaches (e.g., 
CBT/P, GCBT) differ in their means when only the younger children in the approach 
study are considered. The researchers might also ask whether the treatment approaches 
(e.g., CBT/P, GCBT) differ in their means when only the older children in the approach 
are considered. These questions may themselves be of interest, but do not effectively 
address interaction effects. They address simple main effects.  
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To effectively address interaction effects, one must conduct single degree of 
freedom interaction contrasts (Jaccard, 1998; Jaccard & Guilamo-Ramos, 2002). 
Interaction effects can be conceptualized in different ways. One common way involves a 
dependent variable, an independent variable, and a moderator variable (Holmbeck, 1997; 
Jaccard, 1998; Jaccard & Guilamo-Ramos, 2002). The independent variable is the 
assumed cause of the dependent variable. In the case of an interaction, the effect of the 
independent variable on the dependent variable changes depending on the value of a third 
variable, the moderator variable.  
An interaction contrast compares the effect of an independent variable on a 
dependent variable in one group with the comparable effect of an independent variable on 
a dependent variable in another group. For example, an interaction effect compares 
whether the effect of GCBT relative to CBT/P is stronger for older children than it is for 
younger children. This differential effect as a function of age is at the core of an 
interaction effect. Single degree of freedom interaction contrasts are conducted by 
contrasting the main effect of GCBT relative to CBT/P for younger children to the main 
effect of GCBT relative to CBT/P for older children. If the single degree of freedom 
interaction contrast is significant, then one concludes that the interaction is significant 
(e.g., Jaccard & Guilamo-Ramos, 2002). 
None of the studies reviewed above that have tested for moderators reported 
single degree of freedom interaction parameters as recommended by Jaccard and 
Guilamo-Ramos (2002). Instead, interaction analyses were undertaken in some studies 
using multivariate analyses of variance, which were followed by univariate analyses of 
variance on each outcome or simple main effects. Jaccard and Guilamo-Ramos (2002) 
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cautioned against using simple main effects as tests for moderators because this practice 
“fails to formally compare effects in the two groups” (p. 139). This dissertation study 
follows the recommendations by Jaccard and Guilamo-Ramos (2002) to test for treatment 
moderators.  
Treatment Moderators in the Present Study 
The first objective of the present study therefore was to evaluate youth 
characteristics as moderators of treatment outcome. The youth characteristics of interest 
were age, comorbidity with depressive disorders and comorbidity with externalizing 
disorders.  
Youth Age. Although youth age has not been found as a moderator of treatment 
outcome, there are theoretical reasons to believe this would be the case when the 
comparison treatment approaches are CBT/P and GCBT. Two complementary 
hypotheses are feasible to describe the direction of the interaction. First, CBT/P relative 
to GCBT may lower anxiety symptoms more for younger than older children. This 
hypothesis is reasonable because a treatment approaches that aims to improve parenting 
skills (i.e., CBT/P) may have greater therapeutic significance for younger than older 
children relative to a treatment approach that aims to improve social skills (e.g., 
Daleiden, Vasey, & Brown, 1999; Hudson et al., 2002). CBT/P may have a stronger 
impact on treatment outcomes for young children because parents play an influential role 
in the lives of these children. Daleiden et al. (1999), for example, suggested parents play 
a greater role in arranging exposures for younger than older children. Improving 
parenting skills may be important for younger children; other processes may bring about 
anxiety symptom reduction for older children. Older children undergo a process of 
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gaining autonomy from their parents. The need for increased autonomy in older children 
may make parental involvement in treatment a challenging task (e.g., Hudson et al., 
2002). Thus, during the developmental period when parents play an influential role in 
their children’s lives, CBT/P relative to GCBT may lower anxiety symptoms more for 
younger than older children. 
Second, GCBT relative to CBT/P may lower anxiety symptoms more for older 
than younger children. This hypothesis is reasonable because a treatment approach that 
aims to improve social skills and the peer-youth relationship (i.e., GCBT) may have 
greater therapeutic significance for older relative to younger children. Difficulties with 
social skills and peer-youth relationships are most likely to be recognized in adolescence, 
when children spend many hours with peers and developing peer relationships becomes a 
central developmental task (e.g., Parker, Rubin, Erath, Wojslawowicz, & Buskirk, 2006). 
It is also in adolescence that the social skills involved in effective peer-youth 
relationships become increasingly complex (e.g., Parker et al., 2006). Thus, during the 
developmental period when anxious youth are most likely to be identified as having 
difficulties with social skills and peer-youth difficulties, GCBT relative to CBT/P may 
lower anxiety symptoms more for older than younger children. 
Comorbidity. In terms of comorbidity, a recurrent theme throughout RCTs for 
youth anxiety and its disorders are the high rates of comorbidity in the study samples, 
with the most common co-occurring disorders being other anxiety, depressive and 
externalizing disorders (see Ollendick, Jarrett, Grills-Taquechel, Hovey, & Wolff, 2008, 
for a review). Given this high rate of comorbidity, one question that has received 
attention in recent years is whether the presence of comorbidity hinges on treatment 
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outcome. Most of the past research that sought to understand the variability in treatment 
outcome examined comorbidity as a predictor of treatment outcome (e.g., Berman, 
Weems, Silverman, & Kurtines, 2000). Scant research has been conducted on 
comorbidity, in general, and comorbidity with depressive and externalizing disorders, in 
particular, as treatment moderators; the present study will begin to fill this gap in 
knowledge. 
Comorbidity with Depressive Disorders. Consideration of comorbidity with 
depressive disorders as a moderator of treatment outcome is important because these 
problems affect the internal, psychological environment of the child and may hinder 
outcome in some CBTs but not others. GCBT relative to CBT/P may lower anxiety 
symptoms more for youth with comorbid depressive disorders than youth without 
comorbid depressive disorders. This hypothesis is feasible because a treatment approach 
that aims to improve social skills and the peer-youth relationship (i.e., GCBT) may have 
greater therapeutic significance for youth with comorbid depressive disorders than youth 
without comorbid depressive problems. Depressed youth are often described as having 
social skills deficits, which are hypothesized to maintain depressive symptoms 
(Lewinsohn, 1974).  
Depression also disrupts peer-youth relationships by evoking negative responses 
from others and generating interpersonal stress and conflict (Joiner, Coyner, & Blalock, 
1999). Depressed youth rate themselves as less able to resolve conflict and less able to 
provide social support to peers relative to non-depressed youth (e.g., Hammen, Shih, & 
Brennan, 2003). When compared to CBT/P, a treatment approach that targets difficulties 
with social skills and peer-youth relationships (i.e., GCBT) may lower anxiety symptoms 
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more for youth with comorbid depressive disorders than youth without comorbid 
depressive disorders. For the purposes of the moderation analyses, depressive disorders 
were operationally defined in this study by the presence of an affective disorder in 
youth’s diagnostic profile as assessed by the ADIS: C/P (Silverman & Albano, 1996). 
Comorbidity with Externalizing Disorders. Consideration of comorbidity with 
externalizing disorders as a moderator of treatment outcome is also important because 
these problems present themselves outwardly and involve youth acting negatively 
towards others (Campbell, Shaw, & Gilliom, 2000; Hinshaw, 1987). Comorbid 
externalizing disorders may hinder treatment from being effective due to implementation 
difficulties in some CBTs but not others (Campbell et al., 2000; Hinshaw, 1987). Most 
CBTs designed for anxiety and its disorders have as a core component exposure to the 
feared object, people, or events (Silverman, et al., 1999a). However, the CBTs differ in 
the extent to which the child’s parents or the child himself or herself control the out of 
session exposure (Silverman, et al., 1999a, b).  
CBT/P for example equips parents with skills to set appropriate contingencies for 
successful child non-avoidance. CBT/P therefore places parents in control of the child’s 
out of session exposure and approach behavior. In the absence of parent training, GCBT 
relies on the child’s own abilities to regulate emotions when it comes to out of session 
exposure and approach behavior. GCBT therefore places the child in relatively greater 
control of his or her out of session exposure and approach behavior than CBT/P. Given 
that GCBT is relatively more reliant upon the child’s own abilities to regulate emotions 
that youth with comorbid externalizing disorders may not necessarily have, it is 
reasonable that GCBT relative to CBT/P may lower anxiety symptoms less for youth 
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with comorbid externalizing disorders than youth without comorbid externalizing 
disorders.  
The transfer of control model (Silverman & Kurtines, 1996) guided this 
hypothesis. Transfer of control refers to the treatment goal of transferring the skills for 
improving target behaviors from the therapist to the child through a mediator. According 
to the transfer of control model, in approaches that involve the parents (e.g., CBT/P), the 
parents represent the specific mediator of treatment outcome in that a transfer of control 
occurs from the therapist to the child through the parents. In approaches that involve the 
peers (i.e., GCBT), the peers represent the specific mediator of treatment outcome in that 
a transfer of control occurs from the therapist to the child through the peers in the therapy 
group.  
There may be a block in the transfer of control from peers to youth in GCBT due 
to children’s inability to regulate or control their own externalizing problem behaviors. In 
addition, GCBT does not equip parents with skills to set appropriate contingencies to 
successfully manage their child’s non-avoidance and other behaviors such as 
externalizing problems. Comorbidity with externalizing disorders may therefore pose a 
problem for treatment outcome in GCBT. A parallel block in the transfer of control may 
not occur in CBT/P because parents may use skills to set appropriate contingencies to 
successfully manage not only their child’s non-avoidance but also other behaviors such as 
externalizing problem behaviors. Comorbidity with externalizing disorders may therefore 
not pose a problem for treatment outcome in CBT/P. For the purposes of the moderation 
analyses, the present study relied on the presence of an externalizing disorder in youth’s 
diagnostic profile as assessed by the ADIS: C/P (Silverman & Albano, 1996). 
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Studies on Secondary Treatment Outcomes 
As noted at the beginning of this chapter, the third line of approach research seeks 
to evaluate the efficacy of anxiety treatments along secondary or non-targeted problems, 
including depressive symptoms and externalizing problem behaviors. Historically, 
treatment outcome studies have focused on the efficacy of anxiety treatments along 
secondary or non-targeted problems, including anxiety symptoms and disorders. There is 
currently only one study that has focused specifically on secondary outcomes (Suveg, 
Hudson, Brewer, Flannery-Schroeder, Gosch, & Kendall, 2009). A small number of 
studies have reported on secondary outcomes when presenting the main treatment 
outcomes from the respective RCT (e.g., Barrett et al., 1996; Kendall, 1994; Kendall, 
Flannery-Schroeder, Panichelli-Mindel, Southam-Gerow, Henin, & Warman, 1997; 
Manassis et al., 2002; Nauta, Schooling, Emmelkamp, & Minderaa, 2003; Silverman, 
Kurtines, Ginsburg, Weems, Lumpkin, & Hicks-Carmichael, 1999a).  
Depressive Symptoms. Several studies have examined treatment outcome along 
depressive symptoms in ICBT, CBT/P, and GCBT (Barrett et al., 1996; Kendall, 1994; 
Kendall et al., 1997; Manassis et al., 2002; Nauta et al., 2003; Silverman et al., 1999a; 
Suveg et al., 2009). In all of these studies depressive symptoms were assessed using the 
Children's Depression Inventory (CDI; Kovacs, 1981). These studies are summarized 
next in the following order:  ICBT, CBT/P and GCBT. 
Reductions in Depressive Symptoms: ICBT. Silverman et al. (1999a) examined the 
effects of exposure plus contingency management (n = 40), exposure plus cognitive self-
control (n = 41), and an education-support control approach (n = 23) on depressive 
symptoms in youth (6 to 16 years) who were treated for simple phobias. Similar 
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significant reductions in depressive symptoms from pretreatment to posttreatment were 
been found by Kendall in two studies (Kendall, 1994; N = 47 youth; 9 to 13 years; 
Kendall et al., 1997) in which CBT was compared to a waitlist control approach. In both 
of these studies, significant reductions in depressive symptoms among youth who 
received CBT were maintained at 12-month follow-up.  
Reductions in Depressive Symptoms: ICBT vs. CBT/P. Barrett et al. (1996) 
examined the effects of ICBT (n = 28) and CBT/P (n = 25) on depressive symptoms in 
youth (6 to 16 years) treated for anxiety disorders. Significant reductions in depressive 
symptoms were found from pretreatment to post-treatment. Further reductions in 
depressive symptoms were found at 6- and 12-month follow-up. Nauta et al. (2003) 
similarly examined the effects of CBT (n = 29) and CBT/P (n = 30) on depressive 
symptoms in youth (7 to 18 years) treated for anxiety disorders. Results revealed 
significant reductions in depressive symptoms from pretreatment to posttreatment with no 
statistically significant differences between treatment approaches. The effects of 
treatment on depressive symptoms were maintained at 3-month follow-up. 
Suveg et al. (2009) used data from the RCT by Kendall et al. (2008) to examine 
the generalizability of positive treatment effects from the targeted, anxiety symptoms to 
secondary, nontargeted depressive symptoms. Participants were 161 anxious youth (7 to 
14 years) who were randomly assigned to CBT (n = 55), CBT/P (n = 56), and ESA/P (n = 
50). Results revealed significant reductions in depressive symptoms from pretreatment to 
posttreatment with no statistically significant differences between treatment approaches. 
Reductions in depressive symptoms were maintained at 12 month follow-up. There were 
no statistically significant differences in reductions in depressive symptoms based on 
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youth sex and age. There was not a statistically significant interaction between treatment 
approach and youth sex and age, respectively on reductions in depressive symptoms.  
Reductions in Depressive Symptoms: ICBT vs. GCBT. Manassis et al. (2002) 
examined the effects of ICBT (n = 41) and GCBT (n = 47) on depressive symptoms in 
children (ages 8 to 12 years) who were treated for anxiety disorders. Results revealed 
significant reductions in depressive symptoms from pretreatment to posttreatment. There 
were statistically significant greater reductions in depressive symptoms in ICBT relative 
to GCBT. The reason for the superior performance of CBT on depressive symptoms is 
unclear. Manassis et al. (2002) suggested the group approach may have been 
overwhelming for children with social evaluative concerns. The individual treatment 
approach may have offered children more direct reassurance and social approval by the 
therapist, which may work particularly well with anxious children. These possibilities 
may be the reasons why greater reductions in depressive symptoms were unexpectedly 
found in ICBT relative to GCBT. These possibilities highlight the need for further 
research on determining whether specific symptoms are more amenable to one treatment 
approach versus another. Follow-up data were not reported. 
Liber et al. (2008) examined the effects of ICBT (n = 65) and GCBT (n = 62) on 
depressive symptoms in youth (ages 8 to 12 years) who were treated for anxiety 
disorders. Results revealed significant reductions in depressive symptoms from 
pretreatment to posttreatment with no statistically significant differences between 
treatment approaches. Follow-up data were not reported. 
Externalizing Problem Behaviors. Several studies have examined treatment 
outcome along externalizing problem behaviors in ICBT, CBT/P, and GCBT with and 
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without parent involvement (Barrett, 1998; Kendall, 1994; Nauta et al., 2003; Pina, 
Silverman, Fuentes, Kurtines, & Weems, 2003; Suveg et al., 2009). In all of these studies 
externalizing problem behaviors were assessed using the Externalizing broadband scale 
of the Child Behavior Checklist (CBCL-E; Achenbach & Rescorla, 2001). These studies 
are summarized next in the following order: ICBT, CBT/P and GCBT. 
Reductions in Externalizing Symptoms: ICBT 
Kendall (1994) reported significant reductions in externalizing problem behaviors 
at posttreatment and 12 month follow-up among youth (N = 47; ages 9 to 13 years) who 
received ICBT. Similarly, significant reductions in externalizing symptoms were reported 
by Pina et al. (2003) who examined CBT for European American and Hispanic Latino 
youth. Both European American and Hispanic Latino youth demonstrated significant 
reductions in externalizing problem behaviors at posttreatment. Significant reductions in 
externalizing problem behaviors were maintained at 3, 6, and 12 month follow-up with 
no statistically significant differences between American and Hispanic Latino youth. 
Reductions in Externalizing Symptoms: ICBT vs. CBT/P 
In the study reported above by Suveg et al. (2009), which used data from the RCT 
by Kendall et al. (2008) to examine the relative efficacy of ICBT and CBT/P along 
externalizing problem behaviors. Results revealed significant reductions in externalizing 
problem behaviors from pretreatment to posttreatment on mothers’ and fathers’ CBCL-E 
ratings with no statistically significant differences between treatment approaches. Further 
reductions in externalizing problem behaviors were found at 12 month follow-up again 
with no statistically significant differences between treatments. 
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There were no statistically significant differences based on youth sex at 
posttreatment and 12 month follow-up on parents’ CBCL-E ratings. There was a 
statistically significant difference based on youth age at posttreatment on fathers’ but not 
mothers’ CBCL-E ratings. Younger compared to older children showed significant 
reductions in father-rated externalizing from pretreatment to posttreatment. There was no 
statistically significant interaction between treatment and youth sex and age, respectively 
on reductions in externalizing problem behaviors.  
Nauta et al. (2003) also examined the relative efficacy of ICBT and CBT/P along 
externalizing problem behaviors. Unlike Suveg et al. (2009), who found significant 
reductions in externalizing problem behaviors when the treatment approaches of interest 
were ICBT and CBT/P, Nauta et al. found externalizing problem behaviors remained 
unchanged in both treatments. Perhaps one reason for this finding is because youth in that 
sample were older and had a broader age range distribution than what is typically found 
in RCT for youth anxiety and its disorders (i.e., 7 to 16 years old; e.g., Silverman & 
Motoca, 2011; Silverman et al., 2008). It is possible that at least a subgroup of youth in 
each treatment experienced reductions in externalizing problem behaviors, though this 
remains unknown because possible differences in secondary outcomes as a function of 
youth age were not pursued. This possibility highlights the importance of examining 
secondary outcomes as a function of youth characteristics. Examining secondary 
outcomes as a function of youth characteristics (i.e., sex and age) is a research aim in the 
present study. 
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Reductions in Externalizing Symptoms in GCBT 
Barrett (1998) examined the relative efficacy of GCBT (n = 23), GCBT plus 
parent management (GCBT-PAM; n = 17) and a WLC (n = 20) along externalizing 
problem behaviors in a sample of youth (ages 7 to 14 years). Significantly greater 
pretreatment to posttreatment reductions in externalizing problem behaviors were found 
in the two GCBT approaches relative to the WLC. There were no significant differences 
between GCBT and GCBT-PAM on reductions in externalizing problem behaviors. 
Follow-up data were not reported. 
Summary of Studies on Secondary Outcomes 
In summary, the efficacy of anxiety treatments along secondary or non-targeted 
problems has been demonstrated in six out of seven studies. The only exception was 
Nauta et al. (2003). The studies reviewed represent initial valuable efforts toward 
advancing the knowledge base on the efficacy of anxiety treatments along secondary or 
non-targeted problems. Although extant studies provide initial support for the positive 
effects of treatment on secondary or non-targeted problems, this research leaves several 
gaps in knowledge that are described and addressed through the five aims below.  
Secondary Outcomes in the Present Study 
Treatment Outcome. With rare exceptions (i.e., Silverman et al., 1999a in terms of 
depressive symptoms;  Pina et al., 2003 in terms of externalizing problem behaviors), the 
effects of anxiety CBTs on secondary or non-targeted problems have been examined with  
predominately European American participants because they were the most available to 
researchers. Treatment studies have rarely included ethnic minority groups, particularly 
Hispanic Latino participants (e.g., Silverman et al., 1999a, Silverman et al., 1999b). The 
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low representation of Hispanic Latino participants in treatment studies mirrors, in part, 
the era of efficacy trials during which they were conducted. Prior to Kendall (1994) there 
was no evidence from RCTs that anxiety let alone secondary problems could be reduced. 
RCTs during the 1990s therefore focused on designing treatments and showing that they 
are efficacious or work to reduce anxiety problems.  
That the majority of RCTs were conducted with European American youth also 
means studies on secondary outcomes drew on these samples. The higher representation 
of Hispanic Latino youth in Silverman et al. (1999) and subsequent examinations of 
secondary outcomes (Pina et al., 2003) came about because this team of investigators 
recruited from the population of Miami-Dade County, Florida, which is largely Hispanic 
Latino (1.3 million; 57.3% of the county population; 12.5% of the population in the 
Unites States; U.S. Department of Commerce, 2002). Because Pina et al. (2003) drew on 
Silverman et al.’s RCTs, both of which were conducted during the era of efficacy trials, 
the specific aim of that study were similar to those of other studies on secondary 
outcomes: to produce empirical evidence for treatment efficacy.  
The first specific aim within the second objective was to evaluate whether anxiety 
treatment yields reductions in secondary problems in a relatively larger sample of 
Hispanic Latino youth. Given that past research on secondary outcomes with Hispanic 
Latino youth, included mostly phobic youth. Only Pina et al. (2003) included youth with 
anxiety disorders more broadly but did not examine depressive symptoms. It is not yet 
known whether or not there are favorable secondary outcomes associated with different 
CBT approaches when applied to youth experiencing anxiety disorders more broadly. 
The present study will have another look in an independent sample of predominately 
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Hispanic Latino youth who were treated for other forms of anxiety with different CBT 
approaches. Having another look at secondary treatment outcomes in an independent 
sample will add to the scant literature on secondary treatment outcomes. Evaluation of 
secondary treatment outcomes in an independent sample of Hispanic Latino youth may 
advance understanding about the generalizability (or lack thereof) of positive treatment 
effects from anxiety to related problems in this population when different CBTs are 
applied to youth experiencing a broad range of anxiety disorders. Knowledge that 
emerges from this evaluation could have theoretical and practical value for classification 
efforts and the application of treatment for anxiety and its disorders (e.g., Kraemer et al., 
2002). 
Treatment Approach and Youth Characteristics. There is limited knowledge on 
mean level differences in the effects of treatment on secondary or non-targeted problems 
as a function of approach (i.e., CBT/P versus GCBT) and youth characteristics (i.e., 
youth sex and age). In terms of treatment approach, although CBT reduces depressive 
symptoms and externalizing problem behaviors, the comparison approaches in past 
research are limited (Suveg et al., 2009). No study has compared the relative efficacy of 
CBT/P and GCBT along depressive symptoms and externalizing problem behaviors. This 
is because no existing RCTs compared the relative efficacy of CBT/P and GCBT for 
youth anxiety and its disorders in the same investigation. Studies on secondary outcomes 
would need to draw on such RCTs. It is therefore not yet known whether CBT/P and 
GCBT vary in their relative efficacy to reduce depressive symptoms and externalizing 
problem behaviors. 
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Indeed, although reductions in secondary outcomes likely occur in both CBT/P 
and GCBT, differences as a function of treatment approach are reasonable and may vary 
by secondary problems. It is possible GCBT relative to CBT/P may have a greater 
therapeutic relevance for reducing depressive symptoms. As described earlier, depressed 
youth have difficulties with social skills and peer-youth relationships (Hammen et al., 
2003; Joiner et al., 1999; Lewinsohn, 1974). A treatment approach that targets difficulties 
with social skills and peer-youth relationships (i.e., GCBT) therefore may lower 
depressive symptoms more than a treatment program that does not (i.e., CBT/P). 
It is also possible CBT/P relative to GCBT may have a greater therapeutic 
relevance for reducing externalizing problem behaviors. Anxious youth have difficulties 
regulating not only anxiety, but also externalizing behaviors (Suveg & Zeman, 2004). As 
described earlier, CBT/P and GCBT may differ in the extent to which the child’s parents 
or the child himself or herself control the child’s behavior. A treatment approach that 
equips parents with skills to set appropriate contingencies for successful child behavior 
(i.e., CBT/P) may lower externalizing problem behaviors than a treatment program that 
relies relatively more on the child’s own abilities to regulate emotions (i.e., GCBT). 
Comorbidity may not only moderate the impact of treatment as hypothesized earlier but 
treatment may also have an impact on comorbidity and this may vary by treatment 
approach.  
In terms of youth characteristics, with the exception of Kendall et al. (2008), none 
of the studies reviewed examined whether reductions in secondary outcomes vary as a 
function of youth sex and age. Such examinations are challenging because most RCTs are 
characterized by small sample sizes and wide age ranges (e.g., Silverman et al., 2008). 
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Examinations of secondary outcomes as a function of youth characteristics are reasonable 
because CBTs are grounded on a “traditional model of expert-delivered education” and 
some investigators suggest “boys and older children are more difficult to engage in 
programs of this type” (p. 366, Lyneham & Rapee, 2011). The second specific aim within 
the second objective was to evaluate the efficacy of anxiety treatments in reducing 
secondary problems as a function of approach (i.e., CBT/P versus GCBT) and youth 
characteristics (i.e., sex and age). 
Mediation of Change. Although several studies reported positive effects of 
treatment on secondary problems, the mediators responsible for reductions in depressive 
symptoms and externalizing problem behaviors have not been examined. The present 
study extends past research because it is the first to examine whether changes in primary 
anxiety outcomes significantly mediate changes in secondary outcomes. The third 
specific aim within the second objective therefore was to evaluate whether reductions in 
anxiety symptoms significantly mediate changes in secondary problems.  
Evaluations of mediators are important for theoretical, empirical, and clinical 
reasons. Theoretically, such examinations may advance understanding about the 
processes by which treatment produces positive changes in youths’ depressive and 
externalizing problems. This understanding is important given that empirical knowledge 
about mechanisms and theories of change in child psychotherapy is presently scarce (e.g., 
Kazdin, 2001). This understanding is also important because it can inform classification 
efforts with respect to psychopathology. Empirically, evaluation of mediators could set 
the stage for future investigations into the reasons why anxiety is often comorbid with 
depressive symptoms and externalizing problem behaviors (e.g., Mathew, Pettit, 
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Lewinsohn, Seeley, & Roberts, 2011). Clinically, evaluation of mediators could yield 
knowledge that may inform the development of more efficient and cost effective 
treatments to reduce not only anxiety but also depressive and externalizing problems. 
Such treatments are presently in high demand (Norton, Hayes, & Hope, 2004). 
Directionality of Change. The temporal course of youth anxiety and comorbid 
problems has been identified as an important aspect of comorbidity in need of further 
study (Angold & Costello, 1993). Of interest is whether youth anxiety increases 
depressive symptoms and externalizing problem behaviors and whether the reverse is 
also true. Although bidirectional influences have been incorporated in theoretical models 
of anxiety and comorbid problems in youth, studies have typically focused on 
unidirectional influences on the development, maintenance and change of youth anxiety 
and comorbid problems. Few studies have examined the relation between anxiety and 
depression over time (e.g., Gallerani, Garber, & Martin, 2010; Pine et al., 1998). Pine et 
al. (1998) found major depressive disorders in adolescence significantly predicted a 
threefold increase in the risk for an anxiety disorder in adulthood.  
Intervention designs are suited to clarify issues of directionality of change (Wood, 
McLeod, Sigman, Hwang, & Chu, 2003). Only one study in the child anxiety literature 
examined the issue of directionality of change though an application of parent to child, 
child to parent and bidirectional influences to the study of youth anxiety and parenting 
behaviors (Silverman et al., 2009). The results provided preliminary evidence for the 
bidirectional influences between youth anxiety and parenting behaviors. In that study, the 
child to parent influence was stronger than the traditional parent to child influence. Given 
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that bidirectional influences are theoretically and empirically plausible, it is important to 
consider these influences in the relation between youth anxiety and comorbid problems. 
The fourth specific aim within the second objective therefore was to evaluate the 
directionality of change in the hypothesized mediated relations between reductions in 
anxiety symptoms and changes in secondary problems. Evaluation of directionality may 
point to developmental cascades by which changes in one emotional domain (i.e., 
anxiety) spread to influence changes in other emotional and behavioral domains (i.e., 
depressive symptoms and externalizing problem behaviors) (e.g., Masten et al., 2005). 
Some investigators, for example, believe successful development is the result of the 
acquisition of social, emotional, and cognitive competences (e.g., Cicchetti & Schneider-
Rosen, 1986). Failure to acquire such competences is theorized to influence the 
development of internalizing and externalizing problems by constraining the individuals’ 
abilities for dealing with daily challenges and increasing vulnerability to stress (Masten, 
2006; Patterson & Capaldi, 1990; Sameroff, 2000).  
In dynamic systems theory, more specifically, changes in one area of emotional 
competency are said to set in motion a cascade of consequences that ultimately have large 
developmental effects (Sameroff, 2000; Thelen, 1989). According to Thelen (1989), 
“changes in any one domain therefore may become amplified and have system-wide 
reverberations” (p. 94). Inherent in all theories of development that focus on the 
transactions among individuals is the possibility of spillover effects that result from 
dynamic interactions over time. Anxiety and depressive symptoms, on the one hand, and 
anxiety symptoms and externalizing problem behaviors, on the other hand, may be linked 
through a developmental cascade from one type of difficulty to the other. Treatments that 
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arrest such progressions of maladaptive developmental pathways could provide an 
understanding, even if indirect, of positive and negative cascades in development (e.g., 
Masten et al., 2005; Van Lier & Koot, 2010). 
Indeed, when it comes to the directionality of change, four scenarios are feasible: 
(1) changes in primary anxiety symptoms are associated with changes in secondary 
problems but not vice versa, (2) changes in secondary problems are associated with 
changes in primary anxiety symptoms but not vice versa, (3) changes in both primary 
anxiety symptoms and secondary problems are associated with changes in each other, and 
(4) changes in primary anxiety symptoms are not associated with changes in secondary 
problems. Examining whether changes flow not only from primary anxiety symptoms to 
secondary problems but also from secondary problems to anxiety symptoms will begin to 
illuminate the likely complex nature of the proposed mediated relations between primary 
anxiety and secondary outcome problems. Examining the directionality of change 
between anxiety and comorbid problems is also an important initial step toward 
advancing evidence based-explanations of treatment (Silverman & Motoca, 2011). 
Moderated Mediation. So long as questions of mediation and directionality of 
change have not been examined, evaluations of possible differences in the relations 
between primary anxiety and secondary outcomes as a function of treatment approach 
(i.e., CBT/P versus GCBT) and youth characteristics (i.e., sex and age) are also lacking 
(i.e., moderated mediation). The fifth specific aim within the second objective was to 
evaluate whether the hypothesized mediated relations between changes in primary 
anxiety symptoms and secondary outcome problems are moderated by treatment 
approach (CBT/P versus GCBT) and youth characteristics (sex and age). Evaluation of 
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moderated mediation would provide a closer look into the likely complex relations 
between changes in primary anxiety and secondary outcome problems. 
If significant moderators emerge this would suggest there are differences in the 
function, direction or strength of the hypothesized mediated relations for youth in CBT/P 
versus GCBT, boys versus girls, and younger versus older children. Understanding 
whether these differences exist would inform for whom and under what conditions 
reductions in primary anxiety symptoms result in changes in secondary outcome 
problems. Clarifying the complex temporal relations between primary anxiety and 
secondary outcomes as a function of youth characteristics could inform future 
investigations about the processes underlying these treatments and guide the adaptation 
of sex and age specific approaches (e.g., Gallerani et al., 2010).  
Specificity of Effects. Some investigators suggest that at least two types of anxiety 
can be found in youth (i.e., separation anxiety, fears, obsessions and compulsions versus 
general anxiety and perhaps social anxiety) (e.g., Lahey et al., 2004). General and social 
anxiety symptoms could also be part of the same dimension as depressive symptoms 
(e.g., Lahey et al., 2004). Some exploratory factor analyses of youth self-ratings, for 
example, have yielded a single dimension of anxiety and depression (Achenbach, 1991b). 
Thus, when examining the relations between changes in anxiety and secondary 
depressive symptoms (i.e., third through fifth aim within the second objective above), the 
present study will distinguish between two types of anxiety symptoms (i.e., general and 
social anxiety). The distinction between general and social anxiety in the present study 
when examined in relation to depression may inform classification efforts, such as 
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whether general and social anxiety symptoms are distinct from each other and from 
depressive symptoms.  
The Present Study 
Evident from the Literature Review, the two main issues of interest in the present 
study – treatment moderation and secondary outcomes - have been examined from the 
vantage points of two related, yet disparate lines of psychotherapy research. The present 
study will integrate these two lines of psychotherapy research into one investigation of 
treatment moderation and secondary outcomes. This integration is achieved through 
examining comorbidity, a modifiable youth characteristic, as a treatment moderator, as 
well as a secondary outcome. In addition, youth age, a non-modifiable youth 
characteristic, will be examined as a moderator of treatment outcome. This integration is 
achieved via an analysis of data from an existing RCT of CBT/P and GCBT for youth 
anxiety and its disorders. The following research questions and related hypotheses 
mapping onto the study’s two objectives will be examined.  
Objective I. The first objective of the present study was to tests for youth age, 
comorbidity with depressive disorders and comorbidity with externalizing disorders as 
moderators of treatment outcome at posttreatment and 12month follow up. 
Developmental psychopathology theory and research have guided the selection of these 
variables as potential moderators of treatment outcome. 
Research Question 1.1. Is youth age a moderator of treatment outcome?  
Hypothesis 1.1. Youth age will be a moderator of treatment outcome. CBT/P 
relative to GCBT may lower anxiety symptoms more for younger than older children. Put 
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differently, GCBT relative to CBT/P may lower anxiety symptoms more for older than 
younger children. 
Research Question 1.2. Is comorbidity with depressive disorders a moderator of 
treatment outcome? 
Hypothesis 1.2. Comorbidity with depressive disorders will be a moderator of 
treatment outcome. Two competing hypotheses are feasible to describe the direction of 
the interaction. 
Hypothesis 1.2.1. GCBT relative to CBT/P may lower anxiety symptoms more for 
youth with comorbid depressive disorders than youth without comorbid depressive 
problems. Put differently, CBT/P relative to GCBT may lower anxiety symptoms less for 
youth with comorbid depressive disorders than youth without comorbid depressive 
disorders.  
Hypothesis 1.2.2. CBT/P relative to GCBT may lower anxiety symptoms more for 
youth with comorbid depressive disorders than youth without comorbid depressive 
disorders. 
Research Question 1.3. Is comorbidity with externalizing disorders a moderator of 
treatment outcome? 
Hypothesis 1.3. Comorbidity with externalizing disorders will be a moderator of 
treatment outcome? GCBT relative to CBT/P may lower anxiety symptoms less for youth 
with externalizing problem behaviors than youth without comorbid externalizing problem 
behaviors. 
Simple Main Effects. The present study also pursued exploratory simple main 
effects to evaluate: (1) the differential outcome of the treatment approaches as a function 
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of youth characteristics; and (2) the relative efficacy of the treatment approaches at each 
level of the moderators. 
Objective II. The second objective of the present study was to evaluate the 
efficacy of psychosocial treatments aimed at reducing anxiety and its disorders along 
secondary outcomes (depressive symptoms and externalizing problem behaviors) at 
posttreatment and 12-month follow up.  
Research Question 2.1. Are there statistically significant positive changes in 
secondary, non-targeted, problems following a treatment designed for anxiety and its 
disorders?   
Hypothesis 2.1. There will be significant positive changes in secondary, non-
targeted, problems following a treatment designed for anxiety and its disorders.  
Research Question 2.2. Are the hypothesized positive changes in secondary, non-
targeted, problems following treatment statistically significantly different in CBT/P 
relative to GCBT? 
Hypothesis 2.2. In the absence of past research comparing the relative efficacy of 
CBT/P and GCBT along secondary, nontargeted, problems no hypothesis is made for this 
research question.  
Research Question 2.3. Are the hypothesized positive changes in secondary, non-
targeted, problems following treatment statistically significantly different as a function of 
youth sex and age? 
Hypothesis 2.3. Because there is limited knowledge on mean-level differences in 
the effects of treatment on secondary, nontargeted, problems as a function of youth sex 
and age, no hypothesis is made for this research question. 
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Research Question 2.4. Are reductions in youth anxiety symptoms significant 
mediators of change in secondary, non-targeted, problems (i.e., youth depressive 
symptoms, measured by youth rated CDI; youth externalizing problem behaviors, 
measured by parent rated CBCL-E)?  
Hypothesis 2.4. Reductions in youth anxiety symptoms will be significant 
mediators of changes in secondary, non-targeted, problems (i.e., youth depressive 
symptoms, measured by youth rated CDI; youth externalizing problem behaviors, 
measured by parent rated CBCL-E)?  
Research Question 2.5. What is the directionality of change in the relation 
between reductions in youth anxiety symptoms and changes in youth secondary, non-
targeted, problems? 
Hypothesis 2.5. The directionality of change in the relation between reductions in 
youth anxiety symptoms and changes in youth secondary, non-targeted, problems will be 
reciprocal. As anxiety symptoms decrease, secondary, non-targeted, problems will also 
decrease and vice versa.  
Research Question 2.6. Are the hypothesized bidirectional relations between 
reductions in youth anxiety symptoms and changes in youth secondary, non-targeted, 
problems moderated by treatment approach (i.e., CBT/P; GCBT) and youth 
characteristics (i.e., sex and age)? 
Hypothesis 2.6. Due to the lack of research with regard to the moderating effects 
of treatment approach and youth characteristics on the hypothesized mediated relations 
between reductions in youth anxiety symptoms and changes in youth secondary, non-
targeted, problems, no hypothesis is made for this research question.  
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In evaluating the efficacy of treatment along secondary outcomes, the present 
study used youth report for depressive symptoms and parent report for externalizing 
problem behaviors in separate analyses. This is because studies suggest that particular 
informants may be optimal for different types of problems (Lahey et al., 2004). Youth 
have consistently been shown to be useful informants for anxiety and depressive 
symptoms but not externalizing problem behaviors (e.g., Bird, Gould, & Staghezza, 
1992). According to Lahey et al. (2004), youth may be unable to contribute valid 
information on externalizing behaviors because these problems require judgments about 
broad aspects of behavior relative to other youth. Youth are able, however, to contribute 
valid information on anxiety and depressive because these symptoms characterize more 
specific emotions.  
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CHAPTER III 
METHODOLOGY 
Participants 
Participants in the present study were 183 youth who completed treatment (ages 6 
to 16 years; M = 9.72 years; SD = 2.21; 54% males) and their mothers who presented to 
the Child Anxiety and Phobia Program (CAPP) at Florida International University (FIU). 
The youth’s age range of 6 to 16 years represents the modal age range of the age of onset 
of separation anxiety disorder (SAD), social phobia (SOP), specific phobia, (SP), and 
generalized anxiety disorders (GAD) in the population and is representative of CAPP’s 
referral patterns. Participants were referred to CAPP by pediatricians, school counselors, 
and other mental health professionals. About 75 percent (n = 137) of the sample were 
Hispanic Latinos, 19.7 percent (n = 36) were European Americans, 2.7 percent (n = 5) 
were African Americans, and 2.7 (n = 5) were of other ethnic backgrounds.  
The study’s inclusion criteria included the following, all youth: (A) met criteria 
for a primary diagnosis for a DSM IV anxiety disorder of SAD, SOP, SP, and GAD. All 
diagnoses were reviewed and confirmed at a staff conference directed by Dr. Silverman 
following the administration of the ADIS C/P (Silverman & Albano, 1996), (B) received 
a mean score of 4 or greater on the Clinician's Rating Scale of Severity (see Measures), 
(C) ceased all other  psychosocial treatment upon review  with the Center's clinic staff 
and the service provider, and (D) withdrew from certain psychopharmacological agents 
viewed as confounding the study, upon review with the Center’s psychiatric consultant, 
(E) were between 6 and 16 years old, and (F) had parents or guardians who agreed to 
participate in the youth’s treatment. 
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The study’s exclusion criteria included the following, youth who (A) met as a 
primary diagnosis any Axis 1 DSM-IV disorder other than SAD, SOP, SP, and GAD; or 
(B) failed to withdraw from psychosocial treatment or psychopharmacological agents as 
per study protocol and as per medical supervision; or (C) youth and/or parents met 
diagnoses for any one of the following -- Pervasive Developmental Disorders, Mental 
Retardation, Organic Mental Disorders, Schizophrenia and Other Psychotic Disorders; or 
(D) youth and/or parents showed high likelihood and/or serious intent of hurting 
themselves or others. 
Measures  
Anxiety Disorders Interview Schedule for DSM-IV: Child and Parent Versions 
(ADIS for DSM-IV: C/P; Silverman & Albano, 1996).  The ADIS for DSM-IV: C/P was 
administered to the youth and mother to assess anxiety and related disorders. Interviewers 
assigned diagnoses that youth and mother agreed were most interfering. In cases of 
disagreement, the interviewer considered both informants’ views to derive a final 
diagnosis. In cases of multiple diagnoses, the relative interference of each disorder was 
determined by obtaining interference ratings from each source and prioritizing each 
disorder from most to least interfering or disturbing. The disorder deemed most 
interfering/disturbing was viewed as primary and was targeted in treatment. In addition to 
a primary anxiety diagnosis serving as a study inclusion criterion, diagnostic status was 
an index of clinically significant improvement. The ADIS for DSM-IV: C/P has 
satisfactory to good reliability for specific diagnoses and symptom patterns as well as 
strong correspondence with youths’ anxiety self-ratings (Silverman, Saavedra, & Pina, 
2001).   
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 Children's Manifest Anxiety Scale – Revised (RCMAS; Reynolds & Richmond, 
1978). Child anxiety treatment response was assessed on a specific symptom level from 
the child’s perspective using the RCMAS. The RCMAS is a 37-item self-rating scale to 
which children respond either yes (scored 1) or no (scored 0) to anxious symptoms. Pela 
and Reynolds (1982) reported excellent test-retest reliability (r =. 98) using a three-week 
interval. Significant correlations have been found between the Total Anxiety scale, trait 
anxiety, and fear (rs = .63 to .88) (Ollendick, 1983).  The RCMAS has been used as the 
primary outcome measure in almost all past childhood anxiety trials and has been found 
to be a sensitive measure of change (e.g., Silverman et al., 1999a, b). The alpha 
coefficient in the present sample was .63. 
Multidimensional Anxiety Scale for Children (MASC; March, Parker, Sullivan, 
Stallings, & Connors, 1997). Child anxiety treatment response was assessed on a specific 
symptom level from the child’s perspective also using the MASC. The MASC is 
increasingly being used in childhood anxiety research because it provides for a more 
comprehensive assessment of childhood anxiety. The MASC consists of 39 items 
distributed across four factors: Physical Symptoms, Social Anxiety, Harm Avoidance, 
and Separation Anxiety. Children’s ratings of anxiety symptoms are made on the MASC 
via a 4-point Likert scale. The MASC’s test-retest reliability using a 3-week and 3-month 
interval is satisfactory to excellent (ICCs of .93 and .87, respectively). Adequate 
convergent and divergent validity also has been demonstrated in that shared variance was 
highest for scales sampling symptom domains of anxiety, intermediate for depression, 
and lowest for externalizing symptoms (March et al., 1997). Only the MASC Social 
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subscale was used in the present study. The alpha coefficient for MASC Social in the 
present sample was .83.   
Revised Children's Manifest Anxiety Scale (Parent Version; RCMAS/P). The 
wording of RCMAS items was changed from, “I...” to “My child…” as done in past 
research (e.g., Kendall, 1994; Silverman et al., 1999).  Twenty-eight items are rated either 
Yes or No and scored 1 or 0. Summed items yield a Total Anxiety score. The alpha 
coefficient for RCMAS Total in the present sample was .69.   
Children’s Depression Inventory (CDI; Kovacs, 1981). The CDI contains 27 
items designed to assess cognitive, affective, and behavioral symptoms of youth 
depression. The CDI has a test–retest reliability of .72 (Smucker, Craighead, Craighead, 
& Green, 1986). The CDI has been found to discriminate between psychiatric and non-
clinic samples; the CDI also has been found to correlate with clinicians’ independent 
global depression ratings (r = .55; Kovacs, 1981). The alpha coefficient for CDI Total in 
the present sample was .86.   
Child Behavior Checklist (CBCL; Achenbach, 1991) is a 113-item measure that 
assesses children’s behavior problems. Each item is scored on a 3-point scale (0 = not 
true, 1 = sometimes true, 2 = often true). The CBCL provides scores for the total scale, as 
well as for the Internalizing and Externalizing subscale. Parents’ ratings on the CBCL’s 
Externalizing subscale (CBCL-E) were used as indicator of secondary treatment outcome 
in the present study. CBCL scaled scores have been found to discriminate between clinic-
referred and non-referred youth (Achenbach, 1991). 
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Procedures 
Assessment interviews and questionnaires were administered after parents 
provided informed consent and youth provided informed assent. Assessment interviews 
and questionnaires were generally completed in one session by one diagnostician (a 
doctoral level student). During the child interview, the parent was administered a 
questionnaire battery. Following the child interview, the parent was interviewed and the 
child was administered a questionnaire battery. Measures were administered to all youth 
and parents at pretreatment, at posttreatment and at 12 month follow-up. 
Treatment Approaches and Therapists 
 Participants were randomly assigned to CBT/P or GCBT in blocks of seven. The 
specific approach (CBT/P or GCBT) used to start the random assignment process was 
determined by the toss of a coin. Assignment to treatment in blocks of seven was used to 
avoid delay in the approachion of groups. Treatment manuals for CBT/P and GCBT were 
developed to standardize the content of each treatment session. Nevertheless, therapists 
were advised to consider the developmental needs of the youth and proceed accordingly 
with the treatment protocol. Given the high proportion of Hispanic families in the sample, 
8% of the treatments were delivered in a bilingual approach (English and Spanish) by the 
request of the parent participating in CBT/P.  All group treatments were delivered in 
English. An outline of the basic core program as presented to participants was presented 
in detail by Marin (2010). A brief review of the program is provided below.  
In CBT/P, the youth and parents met with the therapist for a total of 60 minutes. 
CBT/P involved targeting of parenting skills and parent-youth relationships. The main 
therapeutic components involved training parents in managing their children’s anxiety 
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and avoidant behaviors, having parents set appropriate contingencies for successful child 
non-avoidance, and helping parents to enhance their acceptance/warmth toward their 
children with improved communication and problem-solving skills.  
In GCBT, the youth met in the group with the therapist for a total of 60 minutes. 
GCBT involved targeting of social skills and peer-youth relationships. The main 
therapeutic components involved training children in being more helpful and positive 
toward other children in the group in the context of anxiety reduction, having children 
accept the help and support of other group members in role-plays, and training children in 
social skills (e.g., compliment giving, conversational skills). The parents of the youth 
who were  assigned to GCBT also had three brief group meetings (about 30 minutes) 
with each group therapist (at the start of the treatment program, the middle, and the end) 
to be kept abreast about the program and the youth’s tasks and activities similar to past 
RCT (e.g., Barrett, 1998; Flannery-Schroeder & Kendall, 2001). Parents were not 
actively incorporated or involved in the youth’s treatment in GCBT, thereby ensuring 
GCBT’s distinctiveness from CBT/P in terms of their targeting distinct contextual 
variables. The total number of sessions in both CBT/P and GCBT was 12 to 14 sessions. 
Because the two treatment approaches required similar therapeutic skill levels 
therapists were crossed between treatments as recommended by Kazdin (1994). All 
therapists received training in the proper administration of the treatments by Dr. 
Silverman. Emphasis was placed on highlighting the overlap between the treatment 
approaches (e.g., youth exposure) but also in ensuring therapists understood the 
distinctions between the two. Dr. Silverman conducted weekly supervision meetings with 
therapists to prepare for upcoming sessions and process sessions just completed. This 
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included the review of the therapists' treatment notes, listening to a random selection of 
therapists' session tapes and providing ongoing feedback via instructions and role plays. 
Eight doctoral level graduate students in psychology delivered the treatments. There were 
no statistically significant differences between the therapists on any of the primary 
outcome variables (Marin, 2010). 
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CHAPTER IV 
RESULTS 
 
Preliminary Analyses 
 
Outliers.  Outlier analyses were undertaken prior to all major analyses. The 
analyses were both nonmodel based and model based. For the former, multivariate 
outliers were identified by examining leverage indices for each individual and defining an 
outlier as a leverage score four times greater than the mean leverage. There were no 
outliers found in the data using this approach. An additional approach was to use model 
based outlier analysis. This involved randomly selecting an indicator for each variable 
and then regressing that indicator onto an indicator for variables that the endogenous 
variable is assumed to be a linear function of. This analysis uses ordinary least squares 
regression in a limited inapproachion estimation framework. Standardized dfbetas were 
examined for each individual and for each predictor, as well as the intercept. An outlier 
was defined as any case with an absolute standardized dfbeta larger than 1.0. There were 
no outliers found in the data using this approach.  
 Non-Normality.  Univariate indices of skewness and kurtosis were examined to 
determine whether the absolute value of any of these indices was greater than 2.0. Non-
normality was evident in several of the variables. To account for the non-normality, all 
analyses were pursued in MPlus 6 (Muthén & Muthén, 2007) by using a maximum 
likelihood estimator robust to violations of normality based on the Huber-White 
algorithm (Huber, 1967; White, 1980). 
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 Analysis of Missing Data. The first step in the analysis of missing data was to 
determine if there was systematic bias in the patterning of missing data. For a given 
measure, a dummy variable was constructed to indicate the presence or absence of 
missing data on that measure. Associations between these dummy variables and 
demographic as well as other study variables were examined. No significant associations 
were observed, indicating that there was no systematic bias in the patterning of missing 
data.     
Objective I: Treatment Moderation  
1.1. Interaction Contrasts. Multiple regression analyses were used to examine 
youth sex, comorbidity with depressive disorders and comorbidity with externalizing 
disorders as moderators of treatment outcome. The treatment approaches and the 
categorical moderators were dummy coded. Continuous moderators were mean centered 
to allow for easy interpretation of the regression coefficients and circumvent the potential 
for multicollinearity (Aiken & West, 2003; Jaccard & Turrisi, 2003). Product terms were 
created between the dummy coded treatment variable and each of the moderators. A 
multiple regression model was run for each of the moderators using pretreatment anxiety, 
the dummy-coded treatment, the moderator, and the product term to predict posttreatment 
and follow-up anxiety scores on the RCMAS and RCMAS/P, respectively. The statistical 
significance of the product term in the multiple regression models was used to declare 
moderation. To test if the efficacy of CBT/P relative to GCBT was statistically 
significantly different at one level of the moderator compared to another, single degree of 
freedom interaction contrasts were pursued. This corresponds to the last row within each 
set of comparisons in Table 1. For example, the single degree of freedom interaction 
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contrast for youth age compared the mean difference for younger versus older children in 
CBT/P with the mean difference for younger versus older children in GCBT.  
1.2. Simple Main Effects. To examine whether CBT/P and GCBT yielded 
differential outcomes at each level of the moderator variables, simple main effects were 
pursued. This corresponds to the first two rows within each set of comparisons in Table 
1. To test whether the proposed moderator variables yield differential outcomes within 
each treatment approach, an additional set of simple main effects were pursued. This 
corresponds to the third and fourth rows within each set of comparisons in Table 1. Given 
that a limited inapproachion estimation approach was used, no model fit indices are 
reported. Each moderator will be discussed in turn below. 
Youth Age. Age did not moderate treatment outcome based on youth report both at 
posttreatment (B = 0.42, SE = 0.42, 95% CI -0.40 to 1.24, p > .05) and at 12 month 
follow-up (B = 0.25, SE = 0.43, 95% CI = -0.59 to 1.09, p > .05). The simple main effects 
examining the outcome of each treatment approach as a function of age were not 
statistically significant; nor were the simple main effects examining the relative efficacy 
of CBT/P and GCBT separately for younger and older children (see Table 1). 
Age moderated treatment outcome based on parent report at posttreatment (SE = 
.87, SE = .31, 95% CI = 0.34 to 1.37, p = .01) but not at 12 month follow-up (B = .52, SE 
= 0.34, 95% CI = -0.15 to 1.18). The relative difference in the mean residual anxiety 
scores between CBT/P and GCBT at posttreatment was -3.67, p < .05 at age 6; -2.80 at 
age 7, p < .05; -1.93 at age 8, p > .05; 2.40, -1.07 at age 9, p > .05; -.20 at age 10, p > .05; 
.67 at age 11, p > .05; 1.53 at age 12, p > .05; 2.4 at age 13, p < .05; 3.27 at age 14, p < 
.05; 4.13 at age 15, p < .05; 5.01 at age 16, p < .05. For every one year increase in age 
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GCBT lowered anxiety scores by .87 units more than CBT/P, adjusting for pretreatment 
anxiety scores. For children 6 through 8, CBT/P yielded a statistically significantly lower 
mean residual anxiety score than GCBT. For children 9 through 12, CBT/P and GCBT 
did not differ in their mean residual anxiety scores. For children 13 through 16, GCBT 
yielded a statistically significantly lower mean residual anxiety score than CBT/P. CBT/P 
relative to GCBT therefore lowered anxiety scores more for younger children than older 
children. GCBT relative to CBT/P lowered anxiety scores more for older children than 
younger children. 
Guided by the above analyses, the sample was divided into younger (6 to 11 
years) and older children (12 to 16 years) in order to examine simple main effects and 
graph the interaction. The multiple regression model was re-ran using the dummy-coded 
treatment, dummy coded age (younger children = 0; older children = 1) and their product 
term predicting posttreatment scores on the RCMAS/P. The results of this analysis were 
consistent with the above findings with one exception discussed below. The path 
coefficient for the product term predicting posttreatment scores on the RCMAS/P was 
statistically significant (B = 5.18, SE = 1.75, 95% CI = 0.89 to 6.46, p < .01).  
The mean residual posttreatment anxiety for older youth in CBT/P was 8.80; the 
mean residual posttreatment anxiety for older youth in GCBT was 4.89; their mean 
difference was 3.91 (p = .01). GCBT lowered anxiety symptoms more for older youth 
than CBT/P. The mean residual posttreatment anxiety for younger youth in CBT/P was 
8.01; the mean residual posttreatment anxiety for younger youth in GCBT was 9.26; their 
mean difference was -1.26 (p > .05). Using the dummy coded approach to examining 
youth age CBT/P and GCBT did not differ on anxiety symptom reduction when it came 
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to younger children. The mean residual posttreatment anxiety for older youth in CBT/P 
was 8.80; the mean residual posttreatment anxiety for younger youth in CBT/P was 8.01; 
their mean difference was .80, p > .05.The mean residual posttreatment anxiety for older 
youth in GCBT was 4.89; the mean residual posttreatment anxiety for younger youth in 
GCBT was 9.26; their mean difference was -4.37, p < .05. GCBT lowered anxiety 
symptoms more for older youth than younger youth. The interaction was 5.18, p < .01. 
GCBT relative to CBT/P lowered anxiety scores more for older children than younger 
children (see Figure 12). 
Comorbidity with Depressive Disorders. Comorbidity with depressive disorders 
did not moderate treatment outcome based on youth report both at posttreatment (B = 
0.20, SE = 3.59, 95% CI = -6.85 to 7.24, p > 0.05) and 12 month follow-up (B = -0.54, SE 
= 2.82, 95% CI = -6.06 to 4.98, p > .05). Using youth report, the simple main effects 
examining the outcome of each treatment as a function of comorbidity with depressive 
disorders were not statistically significant both at posttreatment and 12 month follow-up. 
The simple main effects examining the relative efficacy of CBT/P and GCBT separately 
for youth with and without comorbid depressive disorders were also not statistically 
significant both at posttreatment and 12 month follow-up (see Table 1). 
Comorbidity with depressive disorders moderated treatment outcome based on 
parent report at posttreatment but not at 12 month follow-up. The path coefficient for the 
product term between dummy-coded treatment and dummy-coded comorbid depressive 
disorders was statistically significant (B = 6.28, SE = 2.51, 95% CI = 0.67 to 10.41, p = 
.01). The mean residual posttreatment anxiety for youth with comorbid depressive 
disorders in CBT/P was 10.12; the mean residual posttreatment anxiety for youth with 
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comorbid depressive disorders in GCBT was 4.67; their mean difference was 5.45, p = 
.02. GCBT relative to CBT/P lowered anxiety scores by 5.45 units more for youth with 
comorbid depressive disorders, adjusting for pretreatment anxiety scores. Put differently, 
CBT/P relative to GCBT lowered anxiety scores by 5.45 units less for youth with 
comorbid depressive disorders. The mean residual posttreatment anxiety for youth 
without comorbid depressive disorders in CBT/P was 8.01; the mean residual 
posttreatment anxiety for youth without comorbid depressive disorders in GCBT was 
8.84; their mean difference was -.80, p > .05. CBT/P relative to GCBT did not differ in 
their mean residual posttreatment anxiety scores for youth without comorbid depressive 
disorders. The interaction was 6.28, p = .01. GCBT relative to CBT/P lowered anxiety 
scores by 6.28 units more for youth with comorbid depressive disorders than youth 
without comorbid depressive disorders, adjusting for pretreatment anxiety scores (see 
Figure 13).  
Also using parent report, the mean residual posttreatment anxiety for youth with 
comorbid depressive disorders in CBT/P was 10.12; the mean residual posttreatment 
anxiety for youth without comorbid depressive disorders in CBT/P was 8.84; their mean 
difference was 2.11 (p > .05) (see Table 1). The mean residual posttreatment anxiety for 
youth with comorbid depressive disorders in GCBT was 4.67; the mean residual 
posttreatment anxiety for youth without comorbid depressive disorders in GCBT was 
8.84; their mean difference was -4.17 (p = .02) (see Table 1). GCBT lowered anxiety 
scores by 4.17 units more for youth with comorbid depressive disorders than youth 
without comorbid depressive disorders, adjusting for pretreatment anxiety scores. 
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Comorbidity with Externalizing Disorders. Comorbidity with externalizing 
disorders did not moderate treatment outcome based on youth report at both 
posttreatment (B = -1.30, SE = 1.95, 95 % CI = -5.13 to 2.52, p > .05) and 12 month 
follow-up (B = 0.58, SE = 2.41, 95 % CI = -4.14 to 5.30, p > .05). Using youth report, the 
simple main effects examining the outcome of each treatment as a function of 
comorbidity with externalizing problem behaviors were not statistically significant both 
at posttreatment and 12 month follow-up. The simple main effects examining the relative 
efficacy of CBT/P and GCBT separately for youth with and without comorbid 
externalizing disorders were also not statistically significant both at posttreatment and 12 
month follow-up (see Table 1).  
Comorbidity with externalizing disorders moderated treatment outcome based on 
parent report at posttreatment but not at 12 month follow-up. The path coefficient for the 
product term between dummy-coded treatment and dummy-coded comorbid 
externalizing disorders was statistically significant (B = -3.88, SE = 1.76, 95% CI = -7.66 
to -0.11, p = .04). The mean residual posttreatment anxiety for youth with comorbid 
externalizing disorders in CBT/P was 7.87; the mean residual posttreatment anxiety for 
youth with comorbid externalizing disorders in GCBT was 10.82; their mean difference 
was -2.94, p = .06. The mean residual posttreatment anxiety for youth without 
externalizing disorders in CBT/P was 8.26; the mean residual posttreatment anxiety for 
youth without comorbid externalizing disorders in GCBT was 7.35; their mean difference 
was .91, p > .05. The interaction was -3.85, p = .04. GCBT relative to CBT/P lowered 
anxiety scores by 3.85 units less for youth with comorbid externalizing disorders than 
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youth without comorbid externalizing disorders, adjusting for pretreatment anxiety scores 
(see Figure 14). 
Also using parent report, the mean residual posttreatment anxiety for youth with 
comorbid externalizing disorders in CBT/P was 7.87; the mean residual posttreatment 
anxiety for youth without comorbid externalizing disorders in CBT/P was 8.26; their 
mean difference was -0.39 (p > .05) (see Table 1). The mean residual posttreatment 
anxiety for youth with comorbid externalizing disorders in GCBT was 10.82; the mean 
residual posttreatment anxiety for youth without comorbid externalizing disorders in 
GCBT was 7.35; their mean difference was 3.46 (p = .01) (see Table 1). GCBT lowered 
anxiety scores by 3.46 units less for youth with comorbid externalizing disorders than 
youth without comorbid externalizing disorders, adjusting for pretreatment anxiety 
scores.  
Objective II: Secondary Outcomes: Depressive Symptoms 
2.1.1.Treatment Outcome. To examine whether 12 to 14 weeks of anxiety 
treatment yields changes in depressive symptoms analyses of variance were pursued in a 
structural equation modeling (SEM) framework collapsing the outcome across 
treatments. The SEM equivalent of a 2X3 between-within subjects analysis of variance 
was conducted on the CDI, with the type of treatment approach (CBT/P and GCBT) 
representing a between-subjects factor and time (pre and post; post and follow-up) 
representing a within-subjects factor. In terms of changes in depressive symptoms from 
pre to post, the main effect for time on the CDI was statistically significant (B = 25.08, p 
< .001).  
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Table 4 presents relevant single degree of freedom contrasts and their associated 
statistics for CDI. The contrasts used non-pooled error terms for the contrasts involving 
repeated measures but pooled terms for the contrasts across the between-subjects factor. 
The mean difference for the main effect of time from pre to post collapsing across 
treatments was 4.31 with post showing a decrease in youth self-ratings of depressive 
symptoms, on average, relative to pre. In terms of post to 12 month follow-up, the main 
effect for time on the CDI was statistically significant (B = 24.99, p < .001). Table 4 
presents relevant single degree of freedom contrasts and their associated statistics for 
CDI. The contrasts used non-pooled error terms for the contrasts involving repeated 
measures but pooled terms for the contrasts across the between-subjects factor. The mean 
difference for the main effect of time collapsing across treatment approach was 0.58 with 
12 month follow-up showing a decrease in youth self-ratings of depressive symptoms, on 
average, relative to post.  
2.2.1. The Relative Efficacy of CBT/P vs. GCBT. Of interest was whether the 
positive changes in secondary depressive symptoms following treatment were statistically 
significantly different in CBT/P relative to GCBT at posttreatment and at 12 month 
follow-up. The interaction effect of treatment approach (CBT/P and GCBT) by time (pre 
and post) was not statistically significant (B = -0.73, p > .05). The interaction effect of 
treatment approach (CBT/P and GCBT) by time (post and follow-up) was not statistically 
significant (B = -0.28, p > .05). 
To determine if the pretreatment to postttreatment time difference in depressive 
symptoms occurred at each treatment approach, simple main effects (SME) contrasts 
were performed. The difference was statistically significant for both treatments with post 
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scores showing a decrease in youth depressive symptoms. The time difference for CBT/P 
was 3.86 and for GCBT it was 4.76. The significant pretreatment to posttreatment time 
difference effects were maintained when the Holm modified Bonferroni method was 
applied to control the experiment-wise error rate at 0.05. 
To determine if the postttreatment to 12 month follow-up time difference in 
depressive symptoms difference occurred at each treatment approach, simple main effects 
(SME) contrasts were performed. The time difference was statistically significant for 
both treatments, with 12 month follow-up scores showing a decrease in youth depressive 
symptoms relative to posttreatment. The time difference for CBT/P was .42 and for 
GCBT it was .70. The significant time difference effects were maintained when the Holm 
modified Bonferroni method was applied to control the experiment-wise error rate at 
0.05.  
2.3.1. Change as a Function of Youth Characteristics. Of interest was whether the 
positive changes in secondary depressive symptoms following treatment were statistically 
significantly different for girls versus boys and younger versus older children. The 
interaction effect of youth sex and time (pre and post) was not statistically significant (z = 
.23, p > .05). The interaction effect of youth sex and time (post and follow-up) was not 
statistically significant (z = -.23, p > .05). The interaction effect of youth age and time 
(pre and post) was not statistically significant (z = .27, p > .05). The interaction effect of 
youth age and time was (post and follow-up) not statistically significant (z = .05, p > .05).  
To determine if the pretreatment to postttreatment and posttreatment to 12 month 
follow-up time difference in depressive symptoms occurred at each level of the 
moderator variables, simple main effects (SME) contrasts were performed. The 
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difference was statistically significant for boys and girls and younger (6 to 11 years) and 
older children (12 to 16 years). Posttreatment scores showed a decrease in youth 
depressive symptoms relative to pretreatment. Twelve month follow-up scores showed a 
decrease in youth depressive symptoms relative to posttreatment. All statistically 
significant time difference effects remained significant when the Holm modified 
Bonferroni method was applied to control the experiment-wise error rate at 0.05. 
SEM. The data were further analyzed using SEM to yield insight into the 
underlying dynamics depicted in Figure 1. Of interest was whether change in youth 
anxiety symptoms significantly mediates change in secondary, non-targeted, problems. 
The SEM analyses require clarification and we use depressive symptoms to explicate the 
modeling approach (see Figure 1). A two valued dummy variable for the two treatment 
approaches (CBT/P versus GCBT) was defined and was assumed to outcome youth 
anxiety and depressive symptoms at the posttreatment (paths a and b in Figure 1). The 
dummy variable was included in the model to be consistent with the study’s design; 
however, the SEM analyses reported here were first conducted collapsing across the two 
treatments. Paths c and d represent traditional autoregressive effects. Paths c represents 
change in anxiety symptoms from pretreatment to posttreatment as an effect of the 
approach collapsed across treatments. Paths d represents change in anxiety symptoms 
from posttreatment to 12 month follow-up as an effect of the approach also collapsed 
across treatments. Paths e and f represent traditional autoregressive effects. Paths e 
represents change in secondary outcome measures from pretreatment to posttreatment as 
an effect of the approach collapsed across treatments. Paths f represents change in 
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secondary outcome measures from posttreatment to 12 month follow-up as an effect of 
the approach also collapsed across treatments (see Figure 1). 
Paths g and h represent contemporaneous effects and estimate the extent to which 
changes in anxiety symptoms from pretreatment to posttreatment and posttreatment to 12 
month follow-up mediate changes in the secondary outcome measures over the same time 
period (paths g and h, respectively in Figure 1). Path g and h represent contemporaneous 
reciprocal causality, in that (a) changes in youth anxiety are assumed to outcome changes 
in depressive symptoms, and (b) changes in depressive symptoms are assumed to 
outcome changes in youth anxiety.  
Paths i and j represent lagged effects. Path i estimates the extent to which changes 
in secondary outcome measures from pretreatment to posttreatment are associated with 
changes in primary anxiety symptoms from posttreatment to 12 month follow-up.  Path j 
estimates the extent to which changes in primary anxiety symptoms from pretreatment to 
posttreatment are associated with changes in the secondary outcome measures from 
posttreatment to follow-up. Paths k and l represent traditional autoregressive effects in 
which change in an outcome from pretreatment to posttreatment is associated with 
change in the same outcome from posttreatment to 12 month follow-up.   
Paths m and n represent whether change in anxiety symptoms between 
pretreatment and posttreatment is associated with the initial level of secondary outcome 
variables (path m) and whether change in secondary outcome variables between the 
immediate posttreatment and the follow-up is associated with the initial level of youth 
anxiety symptoms (path n). Paths o and p represent whether change in youth anxiety 
symptoms between pretreatment and the immediate posttreatment is associated with the 
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initial level of secondary outcome variables (path o) and whether change in youth anxiety 
symptoms between the immediate posttreatment and the follow-up is associated with the 
initial level of secondary outcome variables (path p). 
Covariates. The following covariates were included in the analyses: (1) the 
outcomes measured at pretreatment, (2) youth’s sex, (3) youth’s age, and (3) comorbidity 
status. Paths were included from each of these variables to all endogenous variables. 
Figure 1 excludes the covariates and the correlations between the exogenous variables to 
avoid clutter, but these were included in all model tests.  
Fit Indices. Following the recommendations of Bollen and Long (1993), a variety 
of global fit indices were used, including indices of absolute fit, indices of relative fit and 
indices of fit with a penalty function for lack of parsimony. These include the traditional 
overall chi square test of model fit, which should be statistically non-significant, the Root 
Mean Square Error of Approximation (RMSEA), which should be less than .08 to declare 
satisfactory fit), the p value for the test of close fit, which should be statistically non-
significant, and the Comparative Fit Index (CFI), which should be greater than .95.  
In addition to the global fit indices, more focused tests of fit were pursued. These 
included the standardized residual covariances, which should be between -2.00 and 2.00, 
and modification indices, which should be less than 4.00. The parameter estimates also 
were examined for Heywood cases. Heywood cases are parameter estimates with illogical 
values, such as negative error variances or intercorrelation values with absolute values 
greater than 1.0. Care was taken to ensure there was no specification error. Table 2 
presents the fit indices for the study’s SEM analyses. 
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Clustering Effects. The GCBT approach consisted of 19 separate treatment groups 
of youths in blocks of seven. As a result, the model was adjusted for potential clustering 
effects (19 clusters). Participants in CBT/P were treated as independent from each other 
and each participant was coded as a separated cluster (100 clusters). There were a total of 
119 clusters. Given that traditional regression approaches assume independence of 
observations, intra-class correlation (ICC) coefficients were calculated to examine the 
degree of non-independence of observations as a result of the clustering of participants in 
GCBT. This calculation is important because high ICC inflate the probability for a Type I 
error rate (Blair, Higgins, Topping, & Mortimer, 1983). ICCs of zero or near zero are not 
a concern. Calculation of ICCs revealed coefficients greater than .05. These coefficients 
were large enough to warrant adjusting for clustering effects attributable to GCBT using 
the CLUSTER command in MPlus.  
2.4.1. Mediation of Change. In terms of mediation, the joint significance test was 
used to test for significant effects (MacKinnon, Lockwood, Hoffman, West, & Sheets, 
2002). Figure 1 represents the model that was tested in which changes in primary anxiety 
symptoms were hypothesized to mediate changes in secondary, non-targeted, depressive 
symptoms. This model yielded a good fit to the data (χ2 (1) = .51, p > .05; RMSEA < 
.001, p = .57; CFI = 1.0; SRMR = .007). More focused tests of fit revealed no 
theoretically meaningful or sizable modification indices. There were no absolute 
standardized residuals larger than 1.96. The variables in the model were able to account 
for 44% of the variance in the CDI posttreatment scores, and 55% of the variance in the 
CDI follow-up scores. 
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Paths c and j in Figure 1 need to be statistically significant to conclude that 
positive changes in primary anxiety symptoms at posttreatment mediate changes in 
secondary, non-targeted, depressive symptoms at 12 month follow-up. Paths k and h in 
Figure 1 need to be statistically significant to conclude that positive changes in primary, 
targeted, anxiety symptoms at 12 month follow-up mediate changes in secondary, non-
targeted, problems at 12 month follow-up. Paths c and g were both statistically significant 
(path c: B = 0.42, SE = .08, p < .001; 95% CI = .26 to .57; path g: B = .52, SE = .08, p < 
.001; 95% CI = 37 to .68), suggesting that positive changes in primary, targeted, anxiety 
symptoms at posttreatment significantly mediate positive changes in secondary, non-
targeted, depressive symptoms, measured by youth rated CDI at posttreatment (see 
Figure 2). Paths k and h were statistically significant (path k: B = 0.37, SE = 0.08, p < 
.001, 95% CI = 0.23 to 0.52; path h: B = 0.45, SE = 0.14, p = 0.001, 95% CI = 0.21 to 
0.72), suggesting that positive changes in primary, targeted, anxiety symptoms at 12 
month follow-up significantly mediate changes in secondary, non-targeted, depressive 
symptoms, measured by youth rated CDI at 12 month follow-up (see Figure 2). 
Additional analyses were conducted in which changes in social anxiety symptoms 
were hypothesized to mediate changes in depressive symptoms (see Figure 5). This 
model yielded a good fit to the data (χ2 (11) = 12.35, p > .05; RMSEA < .03, p = .69; CFI 
= .99; SRMR = .03). More focused tests of fit revealed no theoretically meaningful or 
sizable modification indices. There were no absolute standardized residuals larger than 
1.96. The variables in the model were able to account for 31% of the variance in the CDI 
posttreatment scores, and 38% of the variance in the CDI follow-up scores. Paths c and g 
in Figure 5 were both statistically significant (path c: B = 0.46, SE = .06, p < .001; 95% 
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CI = .37 to .55; path g: B = .29, SE = .11, p < .001; 95% CI = .07 to .51), suggesting that 
positive changes in social anxiety symptoms at posttreatment significantly mediate 
positive changes in depressive symptoms at posttreatment. Paths k and h in Figure 5 were 
statistically significant (path k: B = 0.35, SE = 0.10, p < .001, 95% CI = 0.23 to 0.52; path 
h: B = 0.34, SE = 0.14, p = 0.01, 95% CI = 0.07 to 0.60), suggesting that positive changes 
in social anxiety symptoms at 12 month follow-up significantly mediate changes in 
depressive symptoms at 12 month follow-up. 
2.5.1. Directionality of Change. The fourth aim of the present study was to 
examine the directionality of change in the relation between positive changes in youth 
primary, targeted, anxiety symptoms and youth secondary, non-targeted, problems. Of 
interest are paths g through l in Figure 1. Again, paths k and l represent traditional 
autoregressive effects in which changes in primary and secondary outcome measures 
from pretreatment to posttreatment are associated with changes in the respective outcome 
measures from posttreatment to follow-up. Paths g and h represent contemporaneous 
reciprocal causality, in that (a) changes in youth anxiety are assumed to outcome changes 
in depressive symptoms, and (b) changes in depressive symptoms are assumed to 
outcome changes in youth anxiety.  
The values of these reciprocal paths cannot be estimated from the data because 
this portion of the model is statistically underidentified. We therefore analyzed the model 
twice: once where paths g and h flowed from youth anxiety to depressive symptoms and 
a second time where paths g and h flowed from youth depressive to anxiety symptoms. 
Paths i and j represent lagged effects. Path i estimates the extent to which changes in 
secondary outcome measures from pretreatment to posttreatment are associated with 
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changes in primary anxiety symptoms from posttreatment to 12 month follow-up. Paths j 
estimates the extent to which changes in primary anxiety symptoms from pretreatment to 
posttreatment are associated with changes in the secondary outcome measures from 
posttreatment to 12 month follow-up.  
The directionality of change was first examined using youth RCMAS and CDI 
measures. The causal flow of paths g at posttreatment and h at 12 month follow-up was 
demonstrated by the previous findings. Paths k and l were statistically significant, 
suggesting that there were significant changes in social anxiety and depressive symptoms 
from posttreatment to 12 month follow-up (see Figure 3). In the second run, when the 
causal direction was reversed, paths e and g (path e: B = 0.34, SE = 0.09, p < .001, 95% 
CI = 0.17 to 0.51; path g: B = 0.48, SE = 0.08, p < 0.001, 96% CI = 0.33 to 0.63) and 
paths l and h were also statistically significant (path l: B = 0.49 SE = 0.10, p < .001, 95% 
CI = 0.28 to 0.69; path h: B = 0.48, SE = 0.08, p < 0.001, 95% CI = 0.09 to 0.39) (see 
Figure 3).  
In both runs, the general hypothesis being tested is whether changes in youth 
primary, targeted, anxiety symptoms are associated with changes in youth secondary, 
non-targeted, depressive symptoms contemporaneously; which direction(s) the causal 
arrow should take is ambiguous because the two models are “redundant” in SEM 
terminology (Silverman et al., 2009). The significance of the paths g and h does not 
provide an answer about the directionality of change between youth primary, targeted, 
anxiety symptoms and youth secondary, non-targeted, depressive symptoms. Similar to 
Silverman et al. (2009), it was assumed that the conclusions regarding the lagged effects 
are the same irrespective of the way the model is represented in terms of paths g and h. 
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To provide an answer about the directionality of change between primary and 
secondary outcome variables, it is important to consider lagged effects (paths i and j in 
Figure 1). Paths i and j need to be statistically significant to conclude that changes in 
primary, targeted, anxiety symptoms and secondary, non-targeted, depressive symptoms 
account for bidirectional changes in each other. Such lagged effects make theoretical 
sense because time must pass in order for changes in anxiety symptoms to influence 
changes in depressive symptoms and for changes in depressive symptoms to influence 
changes in anxiety symptoms. The results revealed that paths i and j were not statistically 
significant (path i: B = 0.05, SE = 0.12, p > .05, 95% CI = - 0.18 to 0.28; path j: B = - 
0.02, SE = .12, p > .05, 95% CI = -0.25 to 0.20) (see Figure 3). Changes in primary 
anxiety symptoms and secondary externalizing problem behaviors do not account for 
bidirectional changes in each other. 
The directionality of change was also examined using the MASC Social subscale 
for social anxiety symptoms and the CDI for depressive symptoms. Similar to the 
previous analyses, paths c and g were both statistically significant suggesting that 
positive changes in social anxiety symptoms at posttreatment significantly outcome 
changes in secondary, non-targeted, depressive symptoms at posttreatment. Paths k and h 
were statistically significant, suggesting that positive changes in social anxiety symptoms 
at 12 month follow-up significantly outcome changes in depressive symptoms over the 
same period of time.  
In the second run, paths e and g at posttretament were statistically significant 
(path e: B = 0.40, SE = 0.09, p < .001, 95% CI = 0.22 to 0.57; path g: B = 0.23, SE = 0.10, 
p < 0.01, 96% CI = 0.05 to 0.42). In the second run, paths l and h were statistically 
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significant (path l: B = 0.41 SE = 0.11, p < .001, 95% CI = 0.19 to 0.60; path h: B = 0.30, 
SE = 0.13, p > 0.05, 95% CI = 0.06 to 0.55) (see Figure 6). In terms of lagged effects, 
path i was statistically significant (path i: B = 0.20, SE = 0.10, p < .05, 95% CI = - 0.18 to 
0.28). Path j, however, was not statistically significant (path j: B = - 0.05, SE = .15, p > 
.05, 95% CI = -0.33 to 0.24) (see Figure 6). The significance of path i suggests that 
changes in youth depressive symptoms outcome changes in social anxiety rather than 
vice versa. Path i is a lagged effect by which it takes time for reductions in youth 
depressive symptoms to work their way through to result in changes in social anxiety 
symptoms. 
2.6.1. Moderated Mediation. The fifth specific aim within the second objective 
was to evaluate whether the hypothesized mediated and bidirectional relations between 
changes in primary anxiety symptoms and secondary outcome problems are moderated 
by treatment approach (CBT/P versus GCBT) and youth characteristics (sex and age). 
This aim was pursued using a product term approach for continuous moderators (i.e., age) 
and a multiple group approach for categorical moderators (i.e., treatment approach and 
sex) (Jaccard & Wan, 1996; Jaccard, Turrisi, & Wan, 1990). The product term approach 
was explained earlier.  
The multiple group approach involved running a given model twice – once with 
the path coefficients constrained equal across the two levels of a given moderator (e.g., 
treatment approach; CBT/P and GCBT) and once with the path coefficients 
unconstrained. A chi square difference test was calculated next by subtracting the chi 
square value and degrees of freedom of the constrained and unconstrained models. The 
statistical significance of the chi square difference was determined by comparing the 
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observed value against a critical value found in a chi square table. The chi square 
difference needs to be statistically significant to conclude that the mediated and 
bidirectional relations were moderated by a given categorical variable. 
Treatment Approach. A multiple group approach was pursued to test the 
moderating effect of treatment approach on the contemporaneous effects from anxiety to 
depressive symptoms, the lagged effect from anxiety symptoms at posttreatment to 
depressive symptoms at 12 month follow-up, and the lagged effect from depressive 
symptoms at posttreatment to anxiety symptoms at 12 month follow-up (paths g through 
j, in Figure 1). The chi square test of model fit for the unconstrained model in which 
paths g through j in Figure 1 were allowed to vary across CBT/P and GCBT was (χ2 (6) 
= 14.03, p > .05). The chi square test of model fit for the unconstrained model in which 
paths g through j in Figure 1 were hypothesized to vary between CBT/P and GCBT was 
(χ2 (2) = .22, p > .05). The chi square difference test between the constrained and 
unconstrained model was statistically significant, χ2 diff. (2) = 10.30, p < .05. The results 
suggest that the unconstrained model for which the paths coefficients were allowed to 
vary between CBT/P and GCBT provided a relatively better fit than the constrained 
model for which the paths were hypothesized to be equal.  
Relaxing paths g through j one by one revealed that the contemporaneous paths h 
flowing from anxiety to depressive symptoms was moderated by treatment approach 
(path h: CBT/P = .82, SE = .18, p < .001; GCBT: B = .34, SE = 14, p = .01) (see Figure 
4). Changes in anxiety symptoms from posttreatment to 12 month follow-up mediated 
changes in depressive symptoms over the same time period and these changes were 
stronger in CBT/P relative to GCBT.  
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The analyses were repeated using youth MASC Social and CDI measures. The chi 
square test of model fit for the unconstrained model in which paths g through j in Figure 
1 were allowed to vary across CBT/P and GCBT was (χ2 (9) = 11.94, p > .05). The chi 
square test of model fit for the constrained model in which paths g through j in Figure 1 
were hypothesized to be equal for CBT/P and GCBT was (χ2 (7) = 17.25, p > .05). The 
chi square difference test between the constrained and unconstrained model was 
statistically significant, χ2 diff. (1) = 5.31, p < .05. The results suggest that the 
unconstrained model for which the paths coefficients were allowed to vary between 
CBT/P and GCBT provided a relatively better fit than the constrained model for which 
the paths were hypothesized to be equal. 
 Relaxing paths g through j one by one revealed that treatment approach 
moderated the contemporaneous paths g and h flowing from social anxiety to depressive 
symptoms at posttreatment and 12 month follow-up, respectively. Path g at posttreatment 
was statistically significant in GCBT (B = 0.60, SE = 0.10, p < .001) but not in CBT/P (B 
= 0.07, SE = 0.14, p > .05) (see Figure 7). The nature of the interaction appears to reflect 
a difference in the fundamental mediated relation between social anxiety and depressive 
symptoms: Changes in social anxiety symptoms from pretreatment to posttreatment 
mediated changes in depressive symptoms over the same time period in GCBT but not 
CBT/P.  
Path g at 12 month follow-up was statistically significant in CBT/P (B = 0.60, SE 
= 0.14, p < .001) but not in GCBT (B = 0.58, SE = 0.13, p > .05) (see Figure 7). Changes 
in social anxiety symptoms from posttreatment to 12 month follow-up mediate changes in 
depressive symptoms over the same time period in CBT/P but not in GCBT. Although 
77 
 
not a moderated path per se, inspection of individual path coefficients for the two 
treatment approaches revealed that path i was statistically significant in CBT/P (B = 0.32, 
SE = 0.14, p = .02) but not GCBT (B = 0.21, SE = 0.12, p > .05) (see Figure 7). This 
suggests that in CBT/P the flow of change is from youth depressive to social anxiety 
symptoms rather than vice versa.  
Youth Sex. A multiple group approach was pursued to test the moderating effect 
of youth sex on the contemporaneous effects from anxiety to depressive symptoms, the 
lagged effect from anxiety symptoms at posttreatment to depressive symptoms at 12 
month follow-up, and the lagged effect from depressive symptoms at posttreatment to 
anxiety symptoms at 12 month follow-up (paths g through j in Figure 1). A dummy 
variable was created to indicate boys (n = 98) and girls (n = 85).  
The chi square test of model fit for the unconstrained model in which paths 
g through j in Figure 1 were allowed to vary for boys and girls was (χ2 (1) = .00, p < .05). 
The chi square test of model fit for the constrained model in which paths g and path j in 
Figure 1 was hypothesized to be equal for boys and girls was (χ2 (2) = .25, p > .05). The 
chi square difference test between the constrained and unconstrained model was not 
statistically significant, χ2 diff. (1) = .25, p > .05. The non-significant chi square 
difference suggests a lack of a significant interaction effect of youth sex on paths g 
through j in Figure 1. The results suggest that the mediated relations between changes in 
anxiety and depressive symptoms are not moderated by youth sex. 
The above analysis was repeated using youth MASC Social and CDI measures. 
The chi square test of model fit for the unconstrained model was (χ2 (20) = 19.77, p > 
.05). The chi square test of model fit for the constrained model was (χ2 (21) = 24.70, p > 
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.05). The chi square difference test between the constrained and unconstrained model was 
statistically significant, χ2 diff. (1) = 4.09, p < .05. The results suggest that the 
unconstrained model for which the paths for boys and girls were allowed to vary 
provided a relatively better fit than the unconstrained model for which the paths were 
hypothesized to be equal for boys and girls.  
Relaxing paths g through j one by one revealed youth sex moderated the lagged 
effect from youth depressive symptoms at posttreatment to youth social anxiety 
symptoms at 12 month follow-up. Path i was statistically significant for girls (B = 0.47, 
SE = 0.16, p = .01) but not for boys (B = 0.13, SE = 0.08, p > .05) (see Figure 8). For 
girls, as changes in depressive symptoms from pretreatment to posttreatment increased, 
changes in social anxiety symptoms from posttreatment to 12 month follow-up increased. 
The results suggest that for girls the flow of change is from depressive to social anxiety 
symptoms rather than vice versa. 
Although not a moderated path per se, inspection of individual path coefficients 
revealed that path g and path h were statistically significant for girls (path g: B = .40, SE 
= .17, p < .05; path h: B = .60, SE = .11, p < .001) but not for boys (path g: B = 0.21, SE = 
0.12, p > .05; path h: B = .24, SE = .20, p > .05) (see Figure 8). Changes in social anxiety 
symptoms from pretreatment to posttreatment and from posttreatment to 12 month 
follow-up mediate changes in depressive symptoms over the respective period of time for 
girls but not for boys. 
Youth Age. Figure 4 represents the model tested. The key paths of interest in 
Figure 4 are r through z. Path r needs to be statistically significant to conclude there is a 
significant interaction effect of youth age on the contemporaneous effect from anxiety 
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symptoms at posttreatment onto depressive symptoms at posttreatment. Path s needs to be 
statistically significant to conclude there is a significant interaction effect of youth age on 
the lagged effect from anxiety symptoms at posttreatment onto depressive symptoms at 
12 month follow-up. Path t needs to be statistically significant to conclude there is a 
significant interaction effect of youth age on the lagged effect from depressive symptoms 
at posttreatment onto depressive symptoms at 12 month follow-up. Path z needs to be 
statistically significant to conclude that there is a significant interaction effect of youth 
age on the contemporaneous effect from anxiety symptoms onto depressive symptoms at 
12 month follow-up. 
The model yielded a good fit to the data. The overall chi square test of model fit 
was not statistically significant (χ2 (3) = 1.80, p > .05). The CFI was 1.00, the RMSEA 
was <.001, the p value for the test of close fit was 0.76, and the SRMR was .003. More 
focused tests of fit revealed no theoretically meaningful or sizeable modification indices. 
Paths r through z were not statistically significant. The results suggest that the mediated 
relations between changes in anxiety and depressive symptoms are not moderated by 
youth age. In addition to the product term analyses, a multiple group approach was 
pursued using younger children (ages 6 to 12) and older children (ages 7 to 16) as the 
grouping variables. No evidence for moderation was found using this approach using 
youth RCMAS and CDI and youth MASC Social and CDI models. The mediated 
relations between changes in social anxiety and depressive symptoms were therefore not 
moderated by youth age. 
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Objective II: Secondary Outcomes: Externalizing Problem Behaviors 
1.2.Treatment Outcome. To evaluate whether 12 to 14 weeks of anxiety treatment 
yielded changes in externalizing problem behaviors analyses of variance were pursued in 
a SEM framework collapsing the outcomes across treatments. The SEM equivalent of a 
2X3 between-within subjects analysis of variance was conducted on the parent rated 
CBCL-E, with the type of treatment approach (CBT/P and GCBT) representing a 
between-subjects factor and time (pre and post; post and follow-up) representing a 
within-subjects factor. In terms of changes in externalizing problem behaviors from 
pretreatment to posttreatment, the main effect for time on the CBCL-E was statistically 
significant (B = 55.94, p < .001). Table 5 presents relevant single degree of freedom 
contrasts and their associated statistics for CBCL-E. The contrasts used non-pooled error 
terms for the contrasts involving repeated measures but pooled terms for the contrasts 
across the between-subjects factor.  
The mean difference for the main effect of time from pretreatment to 
posttreatment collapsing across treatments was 5.84 with posttreatment showing a 
decrease in parent ratings of their child’s externalizing problem behaviors, on average, 
than pretreatment. In terms of posttreatment to 12 month follow-up, the main effect for 
time on the CBCL-E was statistically significant (B = 68.53, p < .001). Table 4 presents 
relevant single degree of freedom contrasts and their associated statistics for CBCL-E. 
The contrasts used non-pooled error terms for the contrasts involving repeated measures 
but pooled terms for the contrasts across the between-subjects factor. The mean 
difference for the main effect of time collapsing across treatment approach was 1.27 with 
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12 month follow-up showing a decrease in parents’ ratings of their child’s externalizing 
problem behaviors, on average, than posttreatment.  
2.2.2. The Relative Efficacy of CBT/P vs. GCBT. Of interest was whether the 
positive changes in secondary, non-targeted externalizing problem behaviors following 
treatment were statistically significantly different in CBT/P relative to GCBT at 
posttreatment and 12 month follow-up. The interaction effect of treatment approach 
(CBT/P and GCBT) by time (pre and post) was not statistically significant (B = -1.20, p > 
.05). The interaction effect of treatment approach (CBT/P and GCBT) by time (post and 
follow-up) was not statistically significant (B = -2.17, p > .05). 
To determine if the pretreatment to posttreatment time difference occurred for 
each treatment approach, simple main effects (SME) contrasts were performed. The 
difference was statistically significant for both treatment approaches with posttreatment 
scores showing a decrease in parent ratings of their child’s externalizing problem 
behaviors, on average, than pretreatment. The time difference for CBT/P was 5.57 and 
for GCBT it was 6.39. The significant pretreatment to posttreatment time difference 
effects were maintained when the Holm modified Bonferroni method was applied to 
control the experiment-wise error rate at 0.05. 
To determine if the posttreatment to 12 month follow-up time difference occurred 
at each treatment approach, simple main effects (SME) contrasts were performed. The 
difference was statistically significant for both treatment approaches with 12 month 
follow-up scores showing a decrease in parents’ ratings of their child’s externalizing 
problem behaviors, on average, than posttreatment. The time difference for CBT/P was 
.60 and for GCBT it was 2.01. The significant posttreatment to 12 month follow-up time 
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difference effects were maintained when the Holm modified Bonferroni method was 
applied to control the experiment-wise error rate at 0.05.  
2.3.2. Change as a Function of Youth Characteristics. Of interest was whether the 
hypothesized positive changes in secondary externalizing problem behaviors following 
treatment were statistically significantly different for girls versus boys and younger 
versus older children. The interaction effect of youth sex and time (pre to post) was not 
statistically significant (B = -.53, p > .05). The interaction effect of youth sex and time 
(post to follow-up) was not statistically significant (B = -1.79, p > .05). The interaction 
effect of youth age and time (pre to post) was not statistically significant (B = .65, p > 
.05). The interaction effect of youth age and time (post to follow-up) was not statistically 
significant (B = -.13, p > .05).  
To determine if the pretreatment to postttreatment and posttreatment to 12 month 
follow-up time difference in externalizing problem behaviors occurred at each level of 
the moderator variables, simple main effects (SME) contrasts were performed. The 
pretreatment to postttreatment and posttreatment to 12 month follow-up time difference 
was statistically significant for boys and girls, younger (6 to 11 years) and older children 
(12 to 16 years). Posttreatment scores showed a decrease in youth externalizing problem 
behaviors relative to pretreatment. Twelve month follow-up scores showed a decrease in 
youth externalizing problem behaviors relative to posttreatment. The time difference 
effects remained significant when the Holm modified Bonferroni method was applied to 
control the experiment-wise error rate at 0.05. 
2.4.2. Mediation of Change. Figure 8 represents the model that was tested in 
which changes in primary anxiety symptoms were hypothesized to mediate changes in 
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secondary externalizing problem behaviors. This model yielded a good fit to the data (χ2 
(3) = 3.76, p > .05; RMSEA < .04, p = .47; CFI = .99; SRMR = .02). More focused tests 
of fit revealed no theoretically meaningful or sizable modification indices. There were no 
absolute standardized residuals larger than 1.96. The variables in the model were able to 
account for 56% of the variance in the CBCL-E posttreatment scores, and 57% of the 
variance in the RCMAS/P follow-up scores.  
Paths c and g were both statistically significant (path c: B = .52, SE = .07, p < 
.001; 95% CI = .39 to .65; path g: B = .74, SE = .14, p < .001; 95% CI = 0.48 to 1.00), 
suggesting that positive changes in primary anxiety symptoms at posttreatment 
significantly mediate positive changes in secondary externalizing problem behaviors, 
measured by parent rated CBCL-E at posttreatment (see Figure 9). Paths k and h in 
Figure 2 were statistically significant (path k: B = .43, SE = .09, p < .001, 95% CI = .25 to 
.61; path h: B = 1.02, SE = 0.15, p = 0.001, 95% CI = .73 to 1.30), suggesting that 
positive changes in anxiety symptoms at 12 month follow-up significantly mediate 
changes in secondary externalizing problem behaviors, measured by parent rated CBCL-
E at 12 month follow-up (see Figure 9). 
2.5.2. Directionality of Change. Paths i and j in Figure 8 need to be statistically 
significant to conclude that changes in primary anxiety symptoms and secondary externalizing 
problems account for bidirectional changes in each other. Paths i and j were not statistically 
significant (path i: B = .08, SE = .05, p > .05, 95% CI = -.01 to .18; path j: B = .01, SE = 
.16, p > .05, 95% CI = -.31 to .33) (see Figure 10). Changes in primary anxiety symptoms 
and secondary externalizing problem behaviors do not account for bidirectional changes 
in each other. 
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2.6.2. Moderated Mediation. Of interest was whether the hypothesized mediation 
and bidirectional relations between changes in youth primary anxiety symptoms and 
youth secondary externalizing problem behaviors are moderated by treatment approach 
(CBT/P; GCBT) and youth characteristics (sex and age). 
Treatment Approach. A multiple group approach was pursued to test the 
moderating effect of treatment approach on the contemporaneous effects from anxiety 
symptoms to externalizing problem behaviors, the lagged effect from anxiety symptoms 
at posttreatment to externalizing problem behaviors at 12 month follow-up, and the 
lagged effect from externalizing problem behaviors at posttreatment to anxiety symptoms 
at 12 month follow-up (paths g through j, in Figure 1). The chi square test of model fit for 
the unconstrained model in which paths g through j in Figure 1 were allowed to vary 
across CBT/P and GCBT was (χ2 (0) = .00, p < .05). The chi square test of model fit for 
the unconstrained model in which paths g through j in Figure 1 were hypothesized to vary 
between CBT/P and GCBT was (χ2 (3) = 1.28, p > .05). The chi square difference test 
between the constrained and unconstrained model was not statistically significant, χ2 diff. 
(3) = 1.28, p > .05. The hypothesized mediated and bidirectional relations between 
changes in anxiety symptoms and externalizing problem behaviors were therefore not 
moderated by treatment approach. 
Youth Sex. A multiple group approach was pursued to assess the moderating 
effect of youth sex on the contemporaneous effects from anxiety symptoms to 
externalizing problem behaviors, the lagged effect from anxiety symptoms at 
posttreatment to externalizing problem behaviors at 12 month follow-up, and the lagged 
effect from externalizing problem behaviors at posttreatment to anxiety symptoms at 12 
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month follow-up (paths g through j in Figure 1). A multiple group model in which paths 
g through j were constrained to be equal for boys and girls yielded (χ2 (21) = 11.41, p > 
.05). A multiple group model for which paths g through j were allowed to vary between 
boys and girls yielded (χ2 (20) = 10.80, p > .05). The chi square difference test between 
the constrained and unconstrained model was statistically significant, χ2 diff. (1) = .61, p 
> .05. The hypothesized mediated and bidirectional relations between changes in anxiety 
symptoms and externalizing problem behaviors were therefore not moderated by youth 
sex. 
Youth Age. Figure 11 represents the model tested. The key paths of interest in 
Figure 4 are r through z. The model in Figure 7 yielded a good fit to the data. The overall 
chi square test of model fit was not statistically significant (χ2 (3) = 1.80, p > .05). The 
CFI was 1.00, the RMSEA was <.001, the p value for the test of close fit was 0.76, and 
the SRMR was .003. More focused tests of fit revealed no theoretically meaningful or 
sizeable modification indices. Path r was not statistically significant (p >.05), suggesting 
a lack of significant interaction effects of youth age on the lagged effect from primary 
anxiety symptoms at posttreatment to secondary externalizing problem behaviors at 12 
month follow-up. Path s was not statistically significant (p >.05), suggesting a lack of 
significant interaction effect of youth age on the lagged effect from secondary 
externalizing problem behaviors at posttreatment to primary anxiety symptoms at 12 
month follow-up. The hypothesized mediation and bidirectional relations between 
changes in youth primary anxiety symptoms and youth secondary externalizing problem 
behaviors are not moderated by youth age. 
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CHAPTER V 
DISCUSSION 
The present study pursued two objectives in the context of a randomized clinical 
trial of cognitive-behavioral therapy with parent (CBT/P) and group (GCBT) 
involvement. The first objective was to examine the variability in treatment outcome. 
There were three specific aims within the first objective, to evaluate: (1) youth 
characteristics (age, depressive, and externalizing disorders) as moderators of treatment 
outcome; (2) the differential outcome of the treatment approaches as a function of youth 
characteristics; and (3) the relative efficacy of the treatment approaches at each level of 
the moderators.  
The second objective was to evaluate the efficacy of anxiety treatments along 
secondary depressive symptoms and externalizing behaviors. There were five specific 
aims within the second objective, to evaluate: (1) whether anxiety treatment yields 
reductions in secondary problems, (2) the efficacy of anxiety treatments in reducing 
secondary problems as a function of approach and youth characteristics, (3) whether 
reductions in anxiety symptoms significantly mediate changes in secondary problems, (4) 
the directionality of change in the hypothesized mediated relations, and (5) whether the 
hypothesized mediated relations are moderated by treatment approach and youth 
characteristics.  
Summary of Dissertation Findings 
In terms of the present study’s first objective, the findings revealed that youth age, 
comorbidity with depressive disorders, and comorbidity with externalizing disorders were 
significant moderators of posttreatment outcome using parent but not youth report. 
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CBT/P relative to GCBT lowered anxiety symptoms more for younger than older 
children. GCBT relative to CBT/P lowered anxiety symptoms more for older than 
younger children. In terms of comorbidity with depressive disorders, GCBT relative to 
CBT/P lowered anxiety symptoms more for youth with comorbid depressive disorders 
than youth without comorbid depressive disorders. In terms of comorbidity with 
externalizing disorders, GCBT relative to CBT/P lowered anxiety symptoms less for 
youth with comorbid externalizing disorders than youth without comorbid externalizing 
disorders. Youth age, comorbidity with depressive disorders, and comorbidity with 
externalizing disorders were not significant moderators of 12 month follow-up outcome 
using youth and parent report. 
In terms of the present study’s second objective, the findings revealed that there 
were statistically significant reductions in secondary, non-targeted, depressive symptoms 
and externalizing problem behaviors at both posttreatment and 12 month follow-up. In 
terms of relative efficacy, reductions in secondary depressive symptoms and 
externalizing problem behaviors were not statistically significantly different in CBT/P 
relative to GCBT. Reductions in secondary, non-targeted, depressive symptoms and 
externalizing problem behaviors occurred in both treatments and were of relative 
strength. In terms of change as a function of youth characteristics, there were statistically 
significant reductions in depressive symptoms and externalizing problem behaviors from 
pretreatment to posttreatment, as well as from posttreatment to 12 month follow-up for 
boys and girls and irrespective of youth age.  
In terms of mediation, the findings revealed that reductions in secondary, non-
targeted, depressive symptoms and externalizing problem behaviors were mediated by 
88 
 
reductions in anxiety symptoms. Treatment yielded significant reductions in targeted 
anxiety symptoms at posttreatment and 12 month follow-up. Reductions in targeted 
anxiety symptoms at posttreatment and 12 month follow-up, in turn, significantly reduced 
non-targeted depressive symptoms and externalizing problem behaviors at the respective 
periods of time. Reductions in secondary, non-targeted, depressive symptoms were also 
mediated by reductions in social anxiety symptoms. 
In terms of directionality of change, there was evidence for reversed directionality 
when the variables of interest were social anxiety and depressive symptoms. The lagged 
path that linked changes in depressive symptoms to subsequent changes in social anxiety 
symptoms was statistically significant. The lagged path that linked changes in social 
anxiety to subsequent changes in depressive symptoms was not significant. These 
findings suggest that the direction of change was from youth depressive to social anxiety 
symptoms rather than vice versa. The directionality of change, however, was qualified or 
moderated by treatment approach and youth sex as further discussed below.  
There was no evidence for reversed directionality when the variables of interest 
were youth general anxiety and depressive symptoms, nor was there evidence for 
reversed directionality when the variables of interest were youth general anxiety 
symptoms and externalizing problem behaviors. The lagged path that linked changes in 
youth general anxiety to subsequent changes in depressive symptoms was not significant, 
nor was the lagged path that linked changes in youth general anxiety symptoms to 
subsequent changes in externalizing problem behaviors. Similarly, the lagged path that 
linked changes in youth depressive to subsequent changes in general anxiety symptoms 
was not statistically significant, nor was the lagged effect that linked changes in youth 
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externalizing problem behaviors to subsequent changes in general anxiety symptoms. 
These findings suggest that the direction of change was from youth general anxiety to 
depressive symptoms and from youth general anxiety to externalizing problem behaviors 
rather than vice versa. 
In terms of moderated mediation, the mediated relations between reductions in 
youth general anxiety and depressive symptoms were moderated by treatment approach. 
The nature of the interaction was one of relative strength rather than a difference in the 
fundamental mediated relation between reductions in youth general anxiety and 
depressive symptoms. Reductions in youth general anxiety symptoms from posttreatment 
to 12 month follow-up mediated reductions in depressive symptoms over the same time 
period and this relation was stronger in CBT/P relative to GCBT.  
The mediated relations between reductions in social anxiety and depressive 
symptoms were moderated by treatment approach and youth sex. The nature of the 
interaction reflected a difference in the fundamental mediated relation between reductions 
in youth social anxiety and depressive symptoms rather than a difference in relative 
strength. In terms of treatment approach, at posttreatment, reductions in social anxiety 
mediated changes in depressive symptoms in GCBT but not CBT/P. Reductions in 
depressive symptoms from pretreatment to posttreatment mediated subsequent changes in 
social anxiety symptoms at 12 month follow-up in CBT/P but not in GCBT. Reductions 
in social anxiety symptoms from posttreatment to 12 month follow-up mediated changes 
in depressive symptoms over the same period of time in CBT/P but not GCBT. These 
moderated mediation findings suggests that in CBT/P the direction of change was from 
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depressive to social anxiety symptoms; in GCBT the direction of change was from social 
anxiety to depressive symptoms.  
In terms of youth sex, the treatments significantly reduced depressive symptoms 
for boys and girls. Reductions in social anxiety mediated changes in depressive 
symptoms for girls but not boys at posttreatment and 12 month follow-up. Also for girls, 
reductions in depressive symptoms at posttreatment mediated subsequent changes in 
social anxiety symptoms at 12 month follow-up.  
Contributions and Implications  
The present study contributes on theoretical, empirical and clinical grounds. The 
main contributions on each of these grounds are summarized below including potential 
implications. 
Theoretical Contributions. In terms of theoretical contributions, knowledge of 
treatment moderators that emerged from the present study can inform understanding of 
psychopathology (e.g., Kazdin, 2001; Kraermer et al., 2002). That CBT/P relative to 
GCBT lowered anxiety symptoms more for younger children than older children is 
consistent with developmental theory which states that parents are most likely to play an 
influential role in the lives of young children (e.g., Daleiden et al., 1999; Hudson et al., 
2002). It is therefore interesting that CBT/P, a treatment program that targeted parenting 
skills and parent-youth relationships, was particularly efficacious for younger children. 
That GCBT relative to CBT/P lowered anxiety symptoms more for older children than 
younger children is also consistent with developmental theory and research showing that 
difficulties with social skills and problematic peer-youth relationships are most likely to 
be recognized in adolescence (Parker et al., 2006). It is also in adolescence that the social 
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skills involved in effective peer-youth relationships become increasingly complex. It is 
therefore interesting that GCBT, a treatment program that targeted social skills and peer-
youth relationships, was particularly effective for older children.  
In terms of comorbidity, GCBT relative to CBT/P lowered anxiety symptoms 
more for youth with comorbid depressive disorders than youth without comorbid 
depressive disorders. Put differently, CBT/P relative to GCBT lowered anxiety symptoms 
less for youth with comorbid depressive disorders than youth without comorbid 
depressive disorders. Finding that comorbid depressive disorders moderated treatment 
outcome is somewhat consistent with an earlier study in which comorbidity with 
depressive disorders was also of interest (Berman et al., 2001). Participants in that study 
were youth who enrolled in one of two RCTs on phobic and anxiety disorders in youth 
(Silverman, et al., 1999a; Silverman et al., 1999b). Participants received an exposure 
based treatment that involved the use of CBT in either an individual or group treatment 
approach. Adverse effects were found for the presence of depressive disorders for the 
overall sample. Separate analyses by treatment approach, however, revealed that it was 
the individual not the group treatment approach that accounted for the findings.  
It therefore appears that in both Berman et al. (2000) and the present study, the 
presence of comorbid disorders did not have adverse effects when youth were assigned to 
a group treatment. In the present study, GCBT relative to CBT/P lowered anxiety 
symptoms more for youth with comorbid depressive disorders than youth without 
comorbid depressive disorders. The training in social skills and peer-youth relationships 
delivered in GCBT may have played an important role in anxiety symptom reduction 
particularly for anxious youth with comorbid depressive disorders. That GCBT relative to 
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CBT/P lowered anxiety symptoms more for youth with comorbid depressive disorders 
than youth without comorbid depressive disorders is consistent with psychopathology 
research showing that youth with depressive symptoms have social skills deficits and 
difficulties with peer-youth relationships (e.g., Joiner et al., 1999; Lewinsohn, 1974). 
The findings also showed that GCBT relative to CBT/P lowered anxiety 
symptoms less for youth with comorbid externalizing disorders than youth without 
comorbid externalizing disorders. These findings are best understood using the transfer of 
control model (Silverman & Kurtines, 1996). It is possible that a block in the transfer of 
control over the skills for improving anxiety occurred in GCBT due to youths’ inability to 
regulate their own externalizing behaviors. This block in the transfer of control over the 
skills for improving anxiety may be especially salient for youth with comorbid 
externalizing disorders than youth without comorbid externalizing disorders. The former 
may find it relatively difficult to regulate their behaviors in ways that interfere with 
anxiety symptom reduction.  
It is possible that a block in the transfer of control over the skills for improving 
anxiety occurred in GCBT also because this approach did not equip parents with skills to 
successfully manage their child’s behaviors. In the absence of parent training, GCBT 
relies on the child’s own abilities to regulate not only anxiety but also externalizing 
problem behaviors. It is possible that a parallel block in the transfer of control did not 
occur in CBT/P because this approach did equip parents with skills to successfully 
manage not only child avoidance but perhaps other behaviors, as well, such as 
externalizing problems. The relative block in the transfer of control over the skills for 
improving anxiety may therefore explain why GCBT compared to CBT/P lowered 
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anxiety symptoms less for youth with comorbid externalizing disorders than youth 
without comorbid externalizing disorders. 
Knowledge of treatment moderators that emerged from the present study also 
illustrates the importance of time and timing in therapeutic change (e.g., Granic, 2006; 
Silverman et al., 2009). It also identifies subgroups of youth with different course of 
illness or therapeutic change (e.g., Kraemer et al., 2002). Indeed, it is interesting that 
youth age and comorbidity impacted treatment outcome at posttreatment but not at 12 
month follow-up. One explanation for the null findings at 12 month follow-up is that by 
then any significant interaction effects wear off. One possibility is that improvements in 
anxiety symptoms from pretreatment to posttreatment among youth with comorbid 
depressive disorders in GCBT and youth with comorbid externalizing disorders in CBT/P 
may wane between posttreatment and 12 month follow-up. Alternatively, perhaps by the 
follow-up youth with comorbid depressive disorders in CBT/P “catch up” in anxiety 
symptom reduction with youth without comorbid depressive disorders in CBT/P, as well 
as youth with comorbid depressive disorders in GCBT. Perhaps by the follow-up youth 
with comorbid externalizing disorders in GCBT “catch up” in anxiety symptom reduction 
with youth without comorbid depressive disorders in GCBT, as well as youth with 
comorbid externalizing disorders in CBT/P.  
Indeed, if treatment impacts comorbidity, by 12 month follow-up anxiety, 
depressive and externalizing problems improve, leaving little, if any variability, in both 
treatment moderators and outcomes to detect interaction and simple main effects. This 
possibility is supported by the secondary outcome findings showing that anxiety, 
depressive and externalizing problems improved over time. It therefore appears that not 
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only does comorbidity impact treatment outcome, but treatment also impacts 
comorbidity. Because treatment moderation was found based on parent but not youth 
report, it is possible that youths’ and parents’ perceptions of treatment outcome become 
increasingly attuned with each other over time, which may be another reason why the 
interaction effects were no longer significant at 12 month follow-up. 
Secondary Outcomes. Knowledge about mediation and directionality of change 
that emerged in the present study could also extend understanding of psychopathology 
with respect to change (Howe et al., 2002). The mediation findings, in particular, advance 
theoretical understanding about the processes by which treatment approaches for youth 
anxiety and its disorders produce changes in youths’ depressive and externalizing 
problems. This understanding is important because knowledge about mechanisms and 
theories of change in child psychotherapy is presently scarce (Kazdin, 2007).  
Knowledge about moderated mediation that emerged in the present study also 
extends understanding of psychopathology with respect to maintenance and change 
(Howe et al., 2002). Indeed, recall that the mediated relations between changes in social 
anxiety and depressive symptoms were moderated by treatment approach and youth sex. 
In terms of treatment approaches, reductions in social anxiety symptoms mediated 
changes in depressive symptoms at posttreatment in GCBT but not CBT/P. The opposite 
was true at 12 month follow-up when reductions in social anxiety mediated changes in 
depressive symptoms in CBT/P but not GCBT. 
In terms of youth sex, reductions in social anxiety symptoms at posttreatment and 
12 month follow-up mediated changes in depressive symptoms over the respective 
periods of time for girls but not boys. Similarly, changes in depressive symptoms at 
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posttreatment mediated subsequent reductions in social anxiety symptoms at 12 month 
follow-up for girls but not boys. 
One possible theoretical implication of the moderated mediation by treatment 
approach is that treatment may have an impact on psychopathology in different 
subgroups, but different approaches show diverse patterns of mediation (e.g., Howe et al., 
2002). Different change processes in the relation between social anxiety and depressive 
symptoms may operate in different approaches. Indeed, although changes in social 
anxiety symptoms from pretreatment to posttreatment occurred in both CBT/P and 
GCBT, changes in social anxiety symptoms mediated reductions in depressive symptoms 
over the same period of time only in GCBT. The moderated mediation by treatment 
approach suggests that improvements in social anxiety from pretreatment to 
posttreatment generalized in improvements in depressive symptoms over the same period 
of time only in GCBT. That changes in social anxiety symptoms from pretreatment to 
posttreatment did not mediate reductions in depressive symptoms in CBT/P suggests that 
in this treatment approach changes in depressive symptoms occurred through other 
mechanisms -- one being changes in youth general anxiety symptoms.  
In terms of directionality of change, the presence of reversed directionality in 
CBT/P suggests that the direction of change in treatment approach was from youth 
depressive to social anxiety symptoms. This finding is important because social anxiety 
and depressive symptoms are frequently co-occurring. This finding is also important 
because socially phobic youth tend to not benefit from CBT when they are clinically 
depressed (Crawley, Beidas, Benjamin, Martin, & Kendall, 2008). This finding suggests 
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that in CBT/P depressive symptoms likely maintain social anxiety and reductions in 
depressive symptoms account for changes in social anxiety.  
The absence of reversed directionality in GCBT suggests that the direction of 
change in GCBT was from social anxiety to depressive symptoms. Finding that the 
direction of change in GCBT was from social anxiety to depressive symptoms is 
consistent with an earlier study examining changes in social anxiety and depressive 
symptoms during group treatment for adults with SOP (Moscovitch, Hofmann, Suvak, & 
In-Albon, 2005). In that study, reductions in social anxiety mediated changes in 
depressive symptoms, but the reverse relation was not found. Group treatment is 
repeatedly argued in the literature to offer opportunities to reduce social anxiety and 
improve social skills in children with SOP (Beidel et al., 2000; Spence et al., 2000). 
Support for reduced social anxiety and improved social skills was found in group based 
CBT programs with social skills training (Beidel et al., 2000; Spence et al., 2000). That 
GCBT reduced social anxiety symptoms from pretreatment to posttreatment and these 
reductions mediated changes in depressive symptoms over the same period of time makes 
theoretical sense because socially anxious and depressed youth encounter difficulties with 
social skills and peer-youth relationships (e.g., Joiner et al., 1999; Lewinsohn, 1974). 
Both of these difficulties were targeted in GCBT. 
From a developmental psychopathology perspective (Cicchetti & Rogosch 1996; 
Cicchetti & Toth, 2009), the differential pattern of mediation and directionality of change 
by treatment approach suggests that the principle of multifinality may be at play when it 
comes to understanding the relation between social anxiety and depressive symptoms. 
Multifinality refers to the notion that a given risk factor may lead to different outcomes. 
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The principle of multifinality is relevant to the present discussion because social anxiety 
and depression are not only highly comorbid, but also have many similar interpersonal 
risk factors, such as social skills deficits and problematic peer-youth relationships (e.g., 
Epkins & Heckler, 2011).  
The differential pattern of mediation and directionality by treatment approach also 
suggests that the principle of equifinality may be at play when it comes to understanding 
the maintenance and change of psychopathology (Howe et al., 2002). Equifinality refers 
to the notion that a given end state can be reached by many potential means. That the 
direction of change in CBT/P was from youth depressive to social anxiety symptoms 
suggests that depressive symptoms maintained social anxiety in this treatment approach. 
It also suggests that in this treatment approach it takes time for reductions in youth 
depressive symptoms to work their way through to result in changes in social anxiety. 
Indeed, in CBT/P, it was not until reductions in youth depressive symptoms worked their 
way through to result in changes in social anxiety symptoms that changes in social 
anxiety symptoms mediated reductions in depressive symptoms.  
One possible theoretical implication of the moderated mediation by youth sex is 
that theories of psychopathology would need to incorporate patterns of moderated 
mediation (Howe et al., 2002). This occurs when a set of maintenance factors function in 
one way for one group of youth and in a different way for another group of youth. If 
those factors are targeted in the approach program, the program will then have different 
effects on psychopathology in the two groups. It therefore follows that the relation 
between social anxiety and depressive symptoms may present itself differently for girls 
versus boys. Indeed, although changes in social anxiety and depressive symptoms were 
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found for both boys and girls, changes in social anxiety symptoms mediated reductions in 
depressive symptoms and vice versa only for girls. This is an interesting finding because 
research shows that rates of social and depressive anxiety symptoms are more common in 
girls than boys (e.g., Aune & Stiles, 2009; La Greca, 1999). This is an interesting finding 
also because it suggests that for boys, variables other than social anxiety mediate changes 
in depressive symptoms. This possibility indicates that there may be multiple and 
potentially different pathways that link social anxiety and depressive symptoms for girls 
versus boys (e.g., Cicchetti & Rogosch 1996; Cicchetti & Toth, 2009; Epkins & Heckler, 
2011).  
Knowledge about treatment moderation and secondary outcomes that emerged in 
the present study could also inform classification efforts. In terms of treatment 
moderation, each comorbidity type – with depressive and externalizing disorders – 
yielded a different pattern of treatment moderation. This suggests that the hypothesized 
moderators – depressive and externalizing disorders -- can be tentatively considered to 
represent distinct psychopathology from each other and from anxiety. In terms of 
secondary outcomes, when examining the relations between changes in anxiety and 
secondary depressive symptoms different patterns of moderated mediation emerged when 
we distinguished between general and social anxiety symptoms. This suggests that 
general and social anxiety can also be tentatively considered to represent distinct 
psychopathology. This distinction is important because some investigators suggest that at 
least two types of anxiety can be found in youth (i.e., separation anxiety, fears, 
obsessions and compulsions versus general anxiety and perhaps social anxiety) (e.g., 
Lahey et al., 2004). 
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Furthermore, although changes in anxiety mediated changes in depressive 
symptoms and externalizing problem behaviors, the path coefficients revealed less than 
perfect relations and explained variances. The proportion of explained variance for 
changes in depressive symptoms was 44% and 31% when examined in relation to general 
and social anxiety symptoms, respectively. These less than perfect explained variances 
suggest that general and social anxiety symptoms are related yet not necessarily part of 
the same dimension as depressive symptoms. The proportion of explained variance for 
changes in externalizing problem behaviors in relation to general anxiety symptoms was 
56%. These less than perfect explained variances suggest that general anxiety symptoms 
and externalizing problem behaviors can also be tentatively considered to represent 
related but distinct psychopathology.  
The suggestions regarding general and social anxiety symptoms, depressive 
symptoms, and externalizing problem behaviors as related but distinct psychopathology 
in the present study are tentative. This is because measures of anxiety symptoms may be 
linked to measures of depressive symptoms and externalizing problem behaviors for a 
number of reasons (Angold et al., 1999; Brady & Kendall, 1992). One set of possibilities 
is methodological, stemming from overlapping constructs or items that may produce 
spurious relations. This methodological possibility is unlikely in the present study 
because each comorbidity type – with depressive and externalizing disorders – yielded a 
different pattern of treatment moderation and there were less than perfect path 
coefficients linking changes in anxiety to changes in secondary problems. The different 
pattern of treatment moderation by comorbidity type coupled with less than perfect path 
coefficients linking changes in anxiety to changes in secondary problems suggests that 
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anxiety, depression, and externalizing problems can be tentatively considered to represent 
distinct yet related psychopathology with at least some nonoverlapping items.  
Nevertheless, psychopathology researchers have paid far less attention to the 
development of strong measures of emotional distress (i.e., anxiety and depression) and 
externalizing problem behaviors than the development of measures of psychopathology 
with nonoverlapping items (e.g., Carter, Silverman, Allen, & Ham, 2008; Stark & 
Laurent, 2001). Research using measures of psychopathology with nonoverlapping items 
is needed to understand the relations between anxiety, depressive, and externalizing 
problems in ways that further informs classification efforts. 
In addition, there are at least two major substantive reasons why anxiety 
symptoms may be linked to depressive symptoms and externalizing problem behaviors. 
The first substantive reason is that anxiety symptoms may be linked to depressive 
symptoms and externalizing problem behaviors simultaneously or in various 
combinations over time, producing phenomena described in developmental 
psychopathology as amplification, snowballing, transactional, cascade, or progressive 
effects (Cicchetti & Tucker, 1994; Dodge & Pettit, 2003; Hinshaw & Anderson, 1996; 
Masten & Coatsworth, 1998; Masten et al., 2005; Patterson, Reid, & Dishion, 1992; 
Sameroff, 2000). Such progressions would account for what appear to be spreading or 
diffusing effects from anxiety to depressive symptoms and from anxiety symptoms to 
externalizing problem behaviors as those observed in the present study.  
Although the first possibility emphasizes a causal relation of anxiety to depressive 
symptoms and of anxiety symptoms to externalizing problem behaviors, it is important to 
point out a second major substantive reason. Anxiety and depressive symptoms, on the 
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one hand, and anxiety symptoms and externalizing problem behaviors, on the other hand, 
could become linked when a third variables contributes to both anxiety and secondary 
problems, “creating a spurious effect, the illusion of a causal link in either direction that 
is actually related to unmeasured variables” (p. 734, Masten et al., 2005). For example, 
the risk literature for social anxiety and depressive symptoms provides potential common 
causes that could underlie relations among these symptoms, including social skills 
deficits, loneliness, and having few or no friends as three relevant risk markers (e.g., 
Epkins & Heckler, 2011). Similarly, the risk literature for anxiety and externalizing 
behaviors provides potential common causes that could underlie relations among these 
problems, including low socioeconomic status, low quality of parenting and parent–youth 
relationships (e.g., Masten et al., 2005). Future research is needed to explore these 
possibilities.  
Empirical Contributions. Past psychotherapy research portrayed treatment 
moderation and secondary outcomes as related yet disparate issues. The present study 
contributes to the empirical literature through the integration of treatment moderation and 
secondary outcomes research into one investigation. The integration of these two lines of 
psychotherapy research in the present study is important because modifiable youth 
characteristics (e.g., comorbidity) can be examined not only as treatment moderators but 
also as secondary outcomes. The findings support the usefulness of this integrative 
approach because comorbidity had a moderating impact on treatment outcome and 
treatment had a modifiable impact on comorbidity. This integration therefore allows for 
understanding the impact of comorbidity on treatment outcome and alternate or 
complementary processes that occur in the extant approaches. The findings underscore 
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the importance of addressing the effects of comorbidity on treatment outcome and the 
effects of treatment on comorbidity. 
In terms of treatment moderation, the relatively large sample size compared to 
past research offered the opportunity to test interactions between youth characteristics 
and treatment approach thereby exploring the possibility that youth who share certain 
demographic and clinical characteristics may benefit more from CBT/P than GCBT, 
whereas youth who share other characteristics may benefit more from GCBT than 
CBT/P.  Evaluation of youth age as a moderator of treatment outcome in the present 
study is important because researchers have long emphasized the need to consider the 
impact of developmentally relevant variables on treatment outcomes (e.g., Holmbeck et 
al., 2003; Kazdin, 2003).  
The present study contributes to research also through its evaluation of 
comorbidity as a moderator of treatment outcome. In particular, the present study 
contributes to research through its evaluation of comorbidity -- with depressive and 
externalizing disorders – as a moderator of treatment outcome. The distinction of 
comorbidity with depressive and externalizing disorders in the present study is an 
important one because the patterns of differential treatment outcome varied by 
comorbidity type. CBT/P relative to GCBT lowered anxiety symptoms less for youth 
with comorbid depressive disorders than youth without comorbid depressive disorders. 
GCBT relative to CBT/P lowered anxiety symptoms less for youth with comorbid 
externalizing disorders than youth without comorbid externalizing disorders. The findings 
underscore the importance of potentially adapting the respective approaches to address 
the specific needs of youth with comorbid depressive and externalizing disorders. 
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The present study makes an empirical contribution also through its evaluation of 
treatment moderation when the comparative treatment approaches are CBT/P and GCBT. 
Research indicates that, on average, CBT/P and GCBT do not differ in their relative 
efficacy when it comes to anxiety symptom reduction (Marin, 2010). Yet these outcomes 
are patterns that are seen on average when youth who have undergone treatment are 
studied as a group. The present study indicates that older youth and youth with comorbid 
depressive disorders compared to younger youth and youth without comorbid depressive 
disorders benefit more from GCBT than CBT/P according to parent report at 
posttreatment. Youth with comorbid externalizing disorders compared to youth without 
comorbid externalizing disorders benefit less from GCBT than CBT/P according to 
parent report at posttreatment. These patterns of differential treatment outcome are 
important because youth with anxiety disorders are heterogeneous in nature and often 
differ in age and comorbidities (e.g., Kendall et al., 2010). Understanding how best to 
treat anxious youth requires knowledge about factors and processes that lead to 
differential treatment outcome (e.g., Kraemer et al., 2002).   
It is important to note that the present study is the first in the youth anxiety 
literature to test for treatment moderators using single degree of freedom interaction 
contrasts as recommended by Jaccard and Guilamo-Ramos (2002). None of the past 
studies on treatment moderation reported single degree of freedom interaction 
parameters. Instead, past studies used the traditional approach to test for moderators. The 
traditional approach to test for moderators involves visual inspection of means and 
analyses of simple main effects in factorial designs (Jaccard & Guilamo-Ramos, 2002). 
The traditional approach to test for moderators is a limitation of past research because the 
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visual inspection of means and analyses of simple main effects do not formerly and 
effectively address interaction effects (Jaccard & Guilamo-Ramos, 2002).  
The present study moved beyond efficacy research to examine anxiety symptom 
reduction as the mechanism responsible for changes in secondary depressive symptoms 
and externalizing problem behaviors (e.g., La Greca et al., 2009). Previous research 
found that anxious youth have difficulty managing worry, sadness, and anger due to their 
experiencing emotions with high intensity (Suveg & Zeman, 2004). Consistent with this 
research, clinical observations show that when parents ask their child to face his or her 
fears, a natural response on the child’s part is to either withdrawn or externalize in 
protest. The findings suggest that once youth learn to apply cognitive skills and 
behavioral strategies to face their fears as part of the treatment approaches, their anxiety 
lessens and they experience a concomitant decrease in depressive and externalizing 
problems. Reductions in anxiety symptoms in other words mediate reductions in 
secondary, non-targeted, depressive symptoms and externalizing problem behaviors.  
The present study moved beyond efficacy research to examine directionality of 
change in the relations between changes in primary anxiety and secondary outcomes. 
Importantly, the directionality of change was examined in the relations between different 
types of anxiety (e.g., general versus social anxiety symptoms) and secondary problems 
(i.e., depressive symptoms, externalizing problem behaviors). The findings support the 
usefulness of this approach because the directionality of change presented differently 
when depressive symptoms were examined in relation to social versus general anxiety 
symptoms. 
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Clinical Implications. The results of this study have several clinical implications. 
First, the results suggest that developmental considerations are important when assigning 
youth to effective approaches. That CBT/P relative to GCBT lowered anxiety symptoms 
more for younger children than older children suggests that the inclusion of training in 
parenting skills and parent-youth relationships may be an important developmental 
consideration when matching youth to effective approaches. That GCBT relative to 
CBT/P lowered anxiety symptoms more for older children than younger children 
suggests that the inclusion of training in social skills and peer-youth relationships may 
also be an important developmental consideration when matching youth to effective 
approaches.  
Second, the results suggest that it is important for clinicians to assess for 
comorbid depressive and externalizing disorders in youth presenting for anxiety treatment 
in order to inform personalized decision making in treatments (NIMH; U.S. Department 
of Health and Human Services, 2008). Ascertaining that youth have both anxiety and 
depressive disorders may lead to a decision to implement a treatment approach that 
involves targeting of social skills and peer-youth relationships, such as GCBT. The main 
therapeutic components of such treatment approaches may involve training children in 
being more helpful and positive toward other children in the group in the context of 
anxiety reduction, having children accept the help and support of other group members in 
role-plays, and training children in social skills (e.g., compliment giving, conversational 
skills).  
Ascertaining that youth have both anxiety and externalizing disorders may lead to 
a decision to implement a treatment approach that involves targeting of parenting skills, 
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such as CBT/P. The main therapeutic components of such treatment approaches may 
involve training parents in managing their children’s anxiety and avoidant behaviors and 
having parents set appropriate contingencies for successful child non-avoidance. 
Implementation of CBT/P may facilitate the transfer of control over the skills for 
improving anxiety even in the presence of externalizing disorders (Silverman & Kurtines, 
1996). Ascertaining that anxious youth do not have comorbid depressive and 
externalizing disorders may lead to a decision to implement either CBT/P or GCBT with 
the expectation that anxiety symptom reduction would be of similar strength irrespective 
of choice between treatment approaches. Choice between treatment approaches for 
anxious youth without comorbid depressive and externalizing disorders could be based 
on pragmatic considerations such as the availability of CBT/P and GCBT and referral 
rates (e.g., Liber et al., 2008). 
Third, reductions in depressive symptoms and externalizing problem behaviors in 
this dissertation study are highly encouraging especially since they were not directly 
targeted. Such reductions support the generalizability of positive treatment effects from 
the targeted, anxiety symptoms to secondary, non-targeted, depressive and externalizing 
problem behaviors through a process of mediation. By elucidating anxiety symptom 
reduction as the mechanism of change, clinicians can focus on anxiety symptom 
reduction not only as a mean in itself but also an opportunity to reduce and stop the 
progression of depressive symptoms and externalizing problem behaviors. Results of the 
present study underscore that secondary outcome measures demonstrate sensitivity to 
treatment and their inclusion in RCTs has practical utility. Given the limited funds often 
available for approach efforts coupled with the time resources necessary to attend 
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multiple treatment programs, targeting anxious youth with CBT approaches is an 
effective, cost- and time-efficient alternative to altering not only anxiety but also 
depressive symptoms and externalizing problem behaviors that co-occur with it. 
Limitations and Directions for Future Research 
Limitations of the present study should be noted. First, although the present study 
drew on the largest RCT to date for youth anxiety and its disorders, this RCT was 
designed to investigate a main effect for treatment and not designed to investigate 
interaction effects. Adequate tests of interaction effects may require an even larger 
sample size than for capturing main effects. One limitation is the relatively small number 
of youth with comorbid depressive and externalizing disorders in each of the treatments. 
The fact that there was evidence of treatment moderation based on comorbidity with 
depressive and externalizing disorders suggests that the presence of comorbidity is an 
important moderator of treatment outcome in CBTs involving parents and peers.  
The sample size considerations when coupled with the above significant findings 
raise the need for an adequately powered treatment study testing whether comorbidity -- 
with depressive and externalizing disorders -- interacts with treatment approaches to 
either strengthen or weaken outcome. Such a treatment study would benefit from 
inclusion of a large number of youth with comorbid depressive and externalizing 
disorders in each of the approaches, as well as a wide range of outcome variables tailored 
to the hypothesized advantages of CBT/P and GCBT for youth with various comorbidity 
profiles. These advantages include an increase in parenting skills in CBT/P for youth with 
comorbid externalizing disorders and an increase in social skills in GCBT for youth with 
comorbid depressive disorders. Future research is also encouraged to determine what 
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modifications in the extant treatment approaches may be needed for youth with various 
comorbidity profiles. 
Second, although developmental psychopathology theory and research findings 
have been invoked in the generation of hypotheses and the explanation of findings, the 
present study was not designed as a direct test of developmental psychopathology. 
Knowledge of moderators that emerged in the present study, nevertheless, helps set the 
stage for future research hypotheses and investigations that could shed light into the 
reasons why the moderators operated the way they did in the present study (Kraemer et 
al., 2002). 
Methodologically, the findings obtained in the present study emphasize the 
importance of assessing multiple domains of psychopathology from baseline and then 
repeatedly through the duration of treatment and follow-up periods in future research. 
Multiple assessments spaced relatively close to each other will allow capturing 
developmental cascades across various domains of psychopathology over time. The 
possibility of developmental cascades underscores the importance of conducting future 
research into “the processes, timing, and conditions of spreading and amplifying effects” 
and of learning “when to do what to interrupt negative progressions” and foster positive 
change (p. 742, Masten et al., 2005). Future research is therefore encouraged to take a 
systematic approach to measurement in order to fully capture developmental cascades. If 
developmental cascades do exists, as the present study began to show, it is possible that 
the best way to stop the progression of one type of problem (e.g., depression) is to 
intervene in another (e.g., anxiety) (Masten et al., 2005). Additional knowledge of what, 
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when, how, and for whom cascades occur will help strategize treatments so they are 
effective in reducing multiple emotional and behavioral problems. 
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Table 1. Single Degree of Freedom and Interaction Contrasts: RCMAS 
 
 
                  Contrast                           Estimate          SE           t Value        p Value             95 % CI 
 
 
Pretreatment to Posttreatment 
SME: CBT/P-GCBT for Younger -0.94 1.26 -0.74 0.46 -3.42 1.54
SME: CBT/P-GCBT for Older -0.01 1.46 -0.01 0.99 -2.88 2.86
SME: Younger, Older for CBT/P -0.7 1.11 -0.62 0.53 -2.88 1.49
SME: Younger, Older for GCBT -1.78 1.72 -1.04 0.3 -5.15 1.58
IC: CBT/P-GCBT for Younger, Older -0.04 0.07 -0.69 0.5 -0.18 0.09
SME: CBT/P-GCBT for MDD 2.34 3.67 0.64 0.52 -4.85 9.53
SME: CBT/P-GCBT for NO MDD -0.58 0.9 -0.64 0.52 -2.35 1.19
SME: MDD-NO MDD f  for CBT/P 1.53 2.41 0.63 0.53 -3.2 6.25
SME: MDD-NO MDD for GCBT 1.37 2.71 0.54 0.58 3.84 6.78
IC: CBT/P-GCBT for MDD, NO MDD 0.7 3.62 0.19 0.85 -6.39 7.78
SME: CBT/P-GCBT for EXT -0.94 1.97 -0.48 0.63 -4.8 2.92
SME: CBT/P-GCBT for NO EXT 0.08 0.89 0.09 0.92 -1.67 1.84
SME: EXT - NO EXT for CBT/P 0.76 1.76 0.68 0.43 -1.41 2.93
SME: EXT - NO EXT for GCBT 1.79 1.5 1.19 0.23 -2.07 4.74
IC: CBT/P-GCBT for EXT, NO EXT -1.3 1.95 -0.67 0.49 -5.13 2.52
Posttreatment to Follow-up
SME: CBT/P-GCBT for Younger 0.68 1.12 0.61 0.54 -1.51 2.87
SME: CBT/P-GCBT for Older 1 1.28 0.78 0.43 -1.51 3.52
SME: Younger, Older for CBT/P -0.7 1.11 -0.62 0.53 -2.88 1.49
SME: Younger, Older for GCBT -1.46 1.51 -0.96 0.34 -4.41 1.5
IC: CBT/P-GCBT for Younger, Older -0.04 0.07 -0.69 0.5 -0.18 0.09
SME: CBT/P-GCBT for MDD -1.89 3.06 -0.62 0.53 -7.88 4.1
SME: CBT/P-GCBT for NO MDD 0.68 0.96 0.71 0.48 -1.2 2.57
SME: MDD-NO MDD f  for CBT/P -1.29 1.57 -0.82 0.41 -4.36 1.78
SME: MDD-NO MDD for GCBT 1.29 2.75 0.45 0.64 -4.11 1.29
IC: CBT/P-GCBT for MDD, NO MDD -1.43 3.05 -0.47 0.64 -7.41 4.56
SME: CBT/P-GCBT for EXT 0.35 2.29 0.15 0.87 -4.15 4.86
SME: CBT/P-GCBT for NO EXT 0.66 0.84 0.77 0.43 -1 2.32
SME: EXT - NO EXT for CBT/P 0.76 1.76 0.68 0.41 -1.41 2.93
SME: EXT - NO EXT for GCBT 1.9 1.66 1.14 0.25 -1.36 5.17
IC: CBT/P-GCBT for EXT, NO EXT 0.58 2.41 0.24 0.81 -4.14 5.3
___________________________________________________________________________________
123 
 
Table 2. Single Degree of Freedom and Interaction Contrasts: RCMAS/P  
 
 
                  Contrast                           Estimate          SE           t Value        p Value             95 % CI 
 
 
Pretreatment to Posttreatment 
SME: CBT/P-GCBT for Younger -0.126 0.82 -1.55 0.12 -3.13 -0.2
SME: CBT/P-GCBT for Older 3.91 1.55 2.51 0.01 0.83 6.98
SME: Younger, Older for CBT/P 0.8 1.13 0.71 0.48 -1.14 3.02
SME: Younger, Older for GCBT -4.37 1.33 -3.3 0.001 1.22 4.77
IC: CBT/P-GCBT for Younger, Older 5.18 1.75 2.94 0.004 0.89 6.46
SME: CBT/P-GCBT for MDD 5.45 2.33 2.34 0.02 0.93 9.87
SME: CBT/P-GCBT for NO MDD -0.83 0.72 -1.15 0.22 -2.21 0.5
SME: MDD-NO MDD f  for CBT/P 2.11 1.77 1.8 0.21 -1.27 5.68
SME: MDD-NO MDD for GCBT -4.17 1.78 -2.34 0.02 -7.2 -0.9
IC: CBT/P-GCBT for MDD, NO MDD 6.28 2.38 2.63 0.01 1.6 10.9
SME: CBT/P-GCBT for EXT -2.94 1.56 -1.88 0.06 -6.19 -0.9
SME: CBT/P-GCBT for NO EXT 0.91 0.85 1.07 0.28 -0.76 2.58
SME: EXT - NO EXT for CBT/P -0.39 1.46 -0.21 0.83 -3.19 2.55
SME: EXT - NO EXT for GCBT 3.46 1.16 2.98 0.01 0.93 6.19
IC: CBT/P-GCBT for EXT, NO EXT -3.85 1.7 -2.26 0.04 0.11 7.66
Posttreatment to Follow-up
SME: CBT/P-GCBT for Younger -1.04 1.09 -0.96 0.33 -3.17 1.09
SME: CBT/P-GCBT for Older 1.38 1.17 1.18 0.24 -0.91 3.31
SME: Younger, Older for CBT/P 1.11 1.1 1.01 0.31 -1.05 2.92
SME: Younger, Older for GCBT -2.32 1.22 -1.9 0.06 -4.71 0.08
IC: CBT/P-GCBT for Younger, Older 0.52 0.34 1.52 0.13 -0.15 1.18
SME: CBT/P-GCBT for MDD 1.69 3.34 0.51 0.61 -4.86 8.25
SME: CBT/P-GCBT for NO MDD -0.24 0.77 -0.31 0.76 -1.92 0.91
SME: MDD-NO MDD f  for CBT/P 0.29 1.9 0.15 0.88 -3.44 4.02
SME: MDD-NO MDD for GCBT -1.63 1.43 -1.14 0.26 -0.11 0.38
IC: CBT/P-GCBT for MDD, NO MDD -1.62 -0.83 3.36 7.54 -1.63 8.34
SME: CBT/P-GCBT for EXT -2.79 1.21 -2.3 0.2 -5.17 -0.8
SME: CBT/P-GCBT for NO EXT 0.23 0.94 0.25 0.81 -1.62 2.08
SME: EXT - NO EXT for CBT/P 0.36 1.92 0.19 0.85 -3.4 4.11
SME: EXT - NO EXT for GCBT 1.58 1.33 1.19 0.23 -1.02 4.1
IC: CBT/P-GCBT for EXT, NO EXT 0.68 1.75 0.39 0.69 -2.75 4.12
___________________________________________________________________________________
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Table 3.  Cell Mean Anxiety Residual Change Scores: Pre to Post 
 
 
 Moderator                                                 CBT/P                                                          GCBT       
___________________________________________________________________________________ 
RCMAS 
       
        Youth Age 
       Younger 
  
7.8 
   
7.87 
Older 
  
7.9 
   
8.03 
        Depressive Disorders 
      MDD 
  
10.75 
   
10.6 
No MDD 
  
8.82 
   
9.34 
        Externalizing Disorders 
      EXT 
  
5.05 
   
6.38 
No EXT 
  
4.12 
   
4.45 
        RCMAS/P 
       
        Youth Age 
       Younger 
  
      7.99 
   
9.26 
Older 
  
      8.80 
   
4.89 
        Depressive Disorders 
      MDD 
  
10.12 
   
4.67 
No MDD 
  
8.01 
   
8.84 
        Externalizing Disorders 
      EXT 
  
7.87 
   
10.82 
No EXT 
  
8.26 
   
7.35 
 
Note. MDD = Major Depressive Disorders; EXT = Externalizing Disorders.  
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Table 4.  Cell Mean Anxiety Residual Change Scores: Post to Follow-up 
____________________________________________________________________________ 
 
Measure 
   
CBT/P 
   
GCBT 
____________________________________________________________________________ 
 
Note. MDD = Major Depressive Disorders; EXT = Externalizing Disorders. 
 
 
 
 
RCMAS
Youth Age
Younger                                                                                                                        7.74 4.55
Older                                                                                                                            5.98 5.02
                                                   
Depressive Disorders
MDD                                                                                                                            5.59 1.21
No MDD                                                                                                                      3.21 3.71
Externalizing Disorders
EXT                                                                                                                             7.39 6.13
No EXT                                                                                                                       4.71 4.03
RCMAS/P
Youth Age
Younger                                                                                                                      2.74 0.52
Older                                                                                                                           1.14 1.96
Depressive Disorders
MDD                                                                                                                           1.33 1.65
No MDD                                                                                                                     0.67 0.84
Externalizing Disorders
EXT                                                              2                                                                2.07 1.88
No EXT                                                                                                                       1.35 1.1
____________________________________________________________________________
126 
 
Table 5. Single Degree of Freedom Contrasts: Secondary Outcomes 
_____________________________________________________________________________________ 
            Contrast                 Parameter SE t Value    p Value      95% CI  
_____________________________________________________________________________________ 
 
Note. ME = Main effects. SME = Simple Main Effects. CDI = Children's Depression 
Inventory. CBCL-E – Children’s Behavior Checklist Externalizing Scale, CBT/P = 
Parent-involvement cognitive behavior treatment. GCBT = Group cognitive behavior 
treatment. FU = Follow-Up. 
 
 
 
 
 
 
 
 
 
 
 
CDI
ME: Pre to Post 19.09 3.94 4.85 <.001 11.38 26.81
ME: Treatment -0.84 0.08 -1.02 >.05 -0.25 0.08
SME: Pre to Post for CBT/P 16.85 4.8 3.51 <.001 7.44 26.25
SME: Pre to Post for GCBT 24.58 8.44 2.98 <.05 8.43 40.73
ME: Post - FU 19.98 4.74 4.74 <.001 10.7 29.71
ME: Treatment -0.08 0.07 -1.14 >.05 -0.21 0.06
SME: Post-FU for CBT/P 19.16 6.23 3.08 <.05 6.96 31.67
SME: Post-FU for GCBT 24.12 7.04 3.43 0.001 3.72 31.8
CBCL-E
ME: Pre to Post 64.9 7.86 8.24 <.001 49.48 80.32
ME: Treatment -1.2 1.36 -0.87 >.05 -3.88 1.47
SME: Pre to Post for CBT/P 39.01 9.59 4.06 <.001 20.21 57.81
SME: Pre to Post for GCBT 66.36 8.93 7.42 <.001 48.84 83.88
ME: Post-FU 60.2 11.47 5.24 0.001 37.72 82.69
ME: Treatment -2.37 1.7 -1.39 >.05 -5.7 0.95
SME: Post-FU for CBT/P 25.17 1.79 1.79 <.05 -10.9 61.22
SME: Post-FU for GCBT 43.25 2.8 2.8 0.01 12.99 73.51
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 Table 6. Means for Variables at Pre, Post and Follow-Up 
________________________________________________________________________                                                                                                                                       
   
    Measure         Pretreatment        Posttreatment              Follow-Up 
________________________________________________________________________ 
   RCMAS             13.29        7.48a                           6.83b 
    RCMAS/P                                   13.25                       8.25a                           6.30b 
    MASC                                            12.49                       8.34a                           7.46b 
    CDI                                               10.47                       6.24a                           5.65b 
    CBCL-E                                        53.17                      47.51a                         46.31b 
________________________________________________________________________    
Note. Posttreatment means with superscript “a” represent statistically significantly 
changes from pretreatment to posttreatment (p < .05). Follow-up means with superscript 
“b” represent statistically significantly changes from posttreatment to follow-up (p < .05). 
RCMAS = Revised Children’s Manifest Anxiety Scale, CDI = Children's Depression 
Inventory, CBCL-E – Children’s Behavior Checklist Externalizing Scale, P = parent.  
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Table 7. Fit Indices for Structural Equation Modeling 
 
 
 
    Model                      Chi Square        CFI     RMSEA   p Close   SRMR 
 
RCMAS and CDI 10.6 0.99 0.02 0.91 0.01 
CDI and RCMAS 4.95 1 <.001 0.77 0.01 
MASC and CDI                                                          2.33 1 <.001 0.69 0.01 
CDI and MASC                                                          2.96 1 <.001 0.93 0.01 
RCMAS/P and CBCL-E                                             12.81 1 <.001 0.9 0.03 
CBCL-E and RCMAS/P                                             11.69 1 <.001 0.8 0.03 
_______________________________________________________________________________________ 
Note. Chi square is goodness of fit index based on maximum likelihood criterion (model 
degrees of freedom = 2), CFI is the Comparative Fit Index, RMSEA is the Root Mean 
Square Error Approximation test and p Close is the p value for close fit associated with 
the RMSEA, SRMR is the Square Root Mean Residual, RCMAS = Revised Children’s 
Manifest Anxiety Scale, CDI = Children's Depression Inventory, MASC = 
Multidimensional Anxiety Scale for Children, CBCL-E – Children’s Behavior Checklist 
Externalizing Scale, P = parent. 
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Note. CBT/P = Parent-Involvement Cognitive Behavior Treatment. GCBT = Group 
Cognitive Behavior Treatment. POM = Primary Outcome Measure; SOM = Secondary 
Outcome Measure. 
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Note. CBT/P = Parent-Involvement Cognitive Behavior Treatment. GCBT = Group 
Cognitive Behavior Treatment. RCMAS = Revised Children’s Manifest Anxiety Scale, 
CDI = Children's Depression Inventory. ** = p < .05. 
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Note. CBT/P = Parent-Involvement Cognitive Behavior Treatment. GCBT = Group 
Cognitive Behavior Treatment. RCMAS = Revised Children’s Manifest Anxiety Scale, 
CDI = Children's Depression Inventory. ** = p < .05. 
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Figure 4. Moderated Mediation: Anxiety and Depressive Symptoms   
 
Note. CBT/P = Parent-Involvement Cognitive Behavior Treatment. GCBT = Group 
Cognitive Behavior Treatment. RCMAS = Revised Children’s Manifest Anxiety Scale, 
CDI = Children's Depression Inventory. Significant paths were moderated by treatment 
approach. Path coefficients for CBT/P are listed first followed by path coefficients for 
GCBT. ** = p < .05; **** = significant interaction. 
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Note. CBT/P = Parent-Involvement Cognitive Behavior Treatment. GCBT = Group 
Cognitive Behavior Treatment. MASC = Multidimensional Anxiety Scale for Children, 
CDI = Children's Depression Inventory. ** = p < .05. 
 
 
 
 
 
 
 
134 
 
 
 
Note. CBT/P = Parent-Involvement Cognitive Behavior Treatment. GCBT = Group 
Cognitive Behavior Treatment. MASC = Multidimensional Anxiety Scale for Children, 
CDI = Children's Depression Inventory. ** = p < .05 
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 Figure 7. Moderated Mediation by Treatment: Social Anxiety and Depressive Symptoms 
 
Note. CBT/P = Parent-Involvement Cognitive Behavior Treatment. GCBT = Group 
Cognitive Behavior Treatment. MASC = Multidimensional Anxiety Scale for Children, 
CDI = Children's Depression Inventory. * = p < .05; **** = significant interaction. 
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Figure 8. Moderated Mediation by Sex and Age: Social Anxiety and Depressive Symptoms   
 
Note. CBT/P = Parent-Involvement Cognitive Behavior Treatment. GCBT = Group 
Cognitive Behavior Treatment. MASC = Multidimensional Anxiety Scale for Children, 
CDI = Children's Depression Inventory. ** = p < .05; **** = significant interaction. 
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Note. CBT/P = Parent-Involvement Cognitive Behavior Treatment. GCBT = Group 
Cognitive Behavior Treatment. RCMAS = Revised Children’s Manifest Anxiety Scale, 
CBCL-E – Children’s Behavior Checklist Externalizing Scale, P = parent; p < .05. 
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Note. CBT/P = Parent-Involvement Cognitive Behavior Treatment. GCBT = Group 
Cognitive Behavior Treatment. RCMAS = Revised Children’s Manifest Anxiety Scale, 
CBCL-E – Children’s Behavior Checklist Externalizing Scale, P = parent; p < .05. 
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Figure 11. Moderated Mediation: Anxiety Symptoms and Externalizing Behaviors 
 
Note. CBT/P = Parent-Involvement Cognitive Behavior Treatment. GCBT = Group 
Cognitive Behavior Treatment. RCMAS = Revised Children’s Manifest Anxiety Scale, 
CBCL-E – Children’s Behavior Checklist Externalizing Scale, P = parent. 
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   GCBT    CBT/P 
 
Figure 12. Treatment Moderation by Depressive Disorders  
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     GCBT           CBT/P 
 
Figure 13. Treatment Moderation by Externalizing Disorders 
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